Section 12

EurekaMag PDF full texts Chapter 11,177


Yamanaka, M.; Hayashi, I.; Fujita, T.; Cha, S.Ho.; Endou, H.; Higashihara, M.; Majima, M. 2002: Potassium-induced increase in renal kallikrein secretion is attenuated in dissected renal connecting tubules of young spontaneously hypertensive rats. International Immunopharmacology 2(13-14): 1957-1964
Lyons, H.J.; Lyons, L.F.; Taraskevich, P.S. 1999: Potassium-induced secretion of melanocyte-stimulating hormone from the melanotrophs of the neurointermediate lobe of the lizard Anolis carolinensis. General and Comparative Endocrinology 116(3): 396-402
Furuya, R.; Kumagai, H.; Sakao, T.; Maruyama, Y.; Hishida, A. 2002: Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis. Nephron 92(3): 576-581
Wuermser, L.A.; Reilly, C.; Poindexter, J.R.; Sakhaee, K.; Pak, C.Y. 2000: Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia. Kidney International 57(2): 607-612
Gabriëls, G.; Stockem, E.; Greven, J. 2000: Potassium-sparing renal effects of trimethoprim and structural analogues. Nephron 86(1): 70-78
Surapaneni, A.; Tillman, R.W.; Kirkman, J.H.; Gregg, P.E.H.; Roberts, A.H.C. 2002: Potassium-supplying power of selected Pallic soils of New Zealand 1. Pot trial study. New Zealand Journal of Agricultural Research 45(2): 113-122
Kakinuma, Y.; Yasumura, K.; Igarashi, K. 1999: Potassium/proton antiport system is dispensable for growth of Enterococcus hirae at low pH. Bioscience Biotechnology and Biochemistry 63(5): 875-878
Santa-María, G.E..; Epstein, E. 2001: Potassium/sodium selectivity in wheat and the amphiploid cross wheat X Lophopyrum elongatum. Plant Science: An International Journal of Experimental Plant Biology 160(3): 523-534
Li-Wei-Min; Lu-Rui-Fang; Guo-Ming; Chen-Yu-Quan; Peng-Xue-Xian 2001: Potato Y potyvirus helper component proteinase enhances long-distance movement of potato X potexvirus. Acta Botanica Sinica 43(9): 935-940
Grünwald, N.J.; Cadena Hinojosa, M.A.; Covarrubias, O.Rubio.; Peña, A.Rivera.; Niederhauser, J.S.; Fry, W.E. 2002: Potato cultivars from the mexican national program: sources and durability of resistance against late blight. Phytopathology 92(7): 688-693
Yevtushenko, D.P.; Shakhovsky, A.M.; Sidorov, V.A. 2000: Potato cytoplasm reconstruction by chloroplast transfer from a wild Solanum species and regeneration of cybrid plants. Biopolimery i Kletka 16(4): 289-296
Liu, Y.; Tortora, G.; Ryan, M.E.; Lee, H.-M.; Golub, L.M. 2002: Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3. Antimicrobial Agents and ChemoTherapy 46(5): 1455-1461
Coker, P.S.; Radecke, J.; Guy, C.; Camper, N.D. 2003: Potato disc tumor induction assay: a multiple mode of drug action assay. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 10(2-3): 133-138
Perombelon, M.C.M. 2002: Potato diseases caused by soft rot erwinias: An overview of pathogenesis. Plant Pathology 51(1): 1-12
Spooner, D.M.; Rivera Pena, A.; Van Den Berg, R.G.; Schueler, K. 2000: Potato germplasm collecting expedition to Mexico in 1997: Taxonomy and new germplasm resources. American Journal of Potato Research 77(4): 261-270
Nazarenko, E.A.; Skryshevskaya, I.V.; Korpan, Y.I. 2002: Potato glycoalkaloids: Dissemination, physical and chemical properties, toxicity and methods of detection. Biopolimery i Kletka 18(6): 478-484
Taliansky, M.; Mayo, M.A.; Barker, H. 2003: Potato leafroll virus: a classic pathogen shows some new tricks. Molecular Plant Pathology 4(2): 81-89
Coleman, W.K.; Donnelly, D.J.; Coleman, S.E. 2001: Potato microtubers as research tools: A review. American Journal of Potato Research 78(1): 47-55
Savenkov, E.I.; Germundsson, A.; Zamyatnin, A.A.; Sandgren, M.; Valkonen, J.P.T. 2003: Potato mop-top virus: the coat protein-encoding RNA and the gene for cysteine-rich protein are dispensable for systemic virus movement in Nicotiana benthamiana. Journal of General Virology 84(Part 4): 1001-1005
Wicha, N.Y.Y.; Bates, E.A.; Moreno, E.M.; Kutas, M. 2003: Potato not Pope: human brain potentials to gender expectation and agreement in Spanish spoken sentences. Neuroscience Letters 346(3): 165-168
Mundy, C.; Creamer, N.G.; Crozier, C.R.; Wilson, L.G.orge 1999: Potato production on wide beds: Impact on yield and selected soil physical characteristics. American Journal of Potato Research 76(6): 323-330
Ralet, M.-Christine; Gueguen, J. 1999: Potato proteins: Composition, recovery and functional properties. Sciences des Aliments 19(2): 147-165
Morrison, I.M.; Cochrane, M.P.; Cooper, A.M.; Dale, M.F.B.; Duffus, C.M.; Ellis, R.P.; Lynn, A.; Mackay, G.R.; Paterson, L.J.; Prentice, R.D.M.; Swanston, J.S.; Tiller, S.A. 2001: Potato starches: Variation in composition and properties between three genotypes grown at two different sites and in two different years. Journal of the Science of Food and Agriculture 81(3): 319-328
Batten, J.S.; Yoshinari, S.; Hemenway, C. 2003: Potato virus X: a model system for virus replication, movement and gene expression. Molecular Plant Pathology 4(2): 125-131
Boonham, N.; Hims, M.; Barker, I.; Spence, N. 1999: Potato virus Y from petunia can cause symptoms of potato tuber necrotic ringspot disease (PTNRD). European Journal of Plant Pathology 105(6): 617-621
Stoykova, D. 2000: Potato virus Y strains and sources of resistance to the pathogen in tobacco. Genetics and Breeding 30(3-4): 37-40
Salazar, L.F.; Muller, G.; Querci, M.; Zapata, J.L.; Owens, R.A. 2000: Potato yellow vein virus: Its host range, distribution in South America and identification as a crinivirus transmitted by Trialeurodes vaporariorum. Annals of Applied Biology 137(1): 7-19
Lucero, H. 1998: Potatoes: Powdery scab. Revista de la Facultad de Ciencias Agrarias Universidad Nacional de Cuyo 30(1): 77-86
Lendinez-Gonzalez, A.; Carnero-Pardo, C.; Iribar-Ibabe, C.; Zunzunegui-Pastor, M., V.; Gonzalez-Maldonado, R. 2000: Potencia discriminante, en el diagnostico de demencia, de los tests neuropsicologicos que componen la Bateria BAGEN. Geriatrika 16(9): 45-47
Gomes, M.P.; Novelli, R.; Faria, V.V.; Zalmon, I.R. 2001: Potencial atrator de peixes osseos em recife artificial no litoral norte do estado do Rio de Janeiro, Brasil. Revista Brasileira de ZoologiaSetembro; 18(3): 779-792
Faria, V.V.; Novelli, R.; Gomes, M.P.; Zalmon, I.R. 2001: Potencial atrator de tubaroes costeiros em recife artificial no litoral norte do estado do Rio de Janeiro, Brasil. Revista Brasileira de ZoologiaSetembro; 18(3): 813-821
Auricchio, Ana-Lucia-Ramos 1999: Potencial da educacao ambiental nos Zoologicos Brasileiros. Publicacoes Avulsas do Instituto Pau Brasil de Historia Natural 1: 1-48
Auad, A., M.; De-Freitas, S.; Barbosa, L., R. 2003: Potencial de alimentacao de Chrysoperla externa (Hagen, 1861) (Neuroptera, Chrysopidae) em diferentes densidades de Uroleucon ambrosiae (Thomas, 1878) (Hemiptera, Aphididae). Revista Brasileira de Entomologia 47(1): 15-18
Da-Silva, G.-Alves; Maia, L.-Costa; Da-Silva, F.-Sergio-Barbosa; Lima, P.-Cesar-Fernandes 2001: Potencial de infectividade de fungos micorrizicos arbusculares oriundos de area de caatinga nativa e degradada por mineracao, no Estado da Bahia, Brasil. Revista Brasileira de Botanica 24(2): 135-143
Martin, J.-Darias; Galarza, F.-Martin; Garcia, M.-Pomar; Fernandez, M.-Hontoria; Diaz-Diaz, E. 2002: Potencial enologico de clones de variedades de uva tradicionalmente cultivadas en tenerife (Espana): Influencia de la virosis de la vid. Alimentaria 39(339): 85-88
Fuzeto, A.-Paula; Lomonaco, C. 2000: Potencial plastico de Cabralea canjerana subsp. polytricha (Adr. Juss.) Penn. (Meliaceae) e seu papel na formacao de ecotipos em areas de cerrado e vereda, Uberlandia, MG. Revista Brasileira de Botanica 23(2): 169-176
Heringer, I.; Moojen, E.-Londero 2002: Potencial produtivo, alteracoes da estrutura e qualidade da pastagem de milheto submetida a diferentes niveis de nitrogenio. Revista Brasileira de Zootecnia 31(2 Suppl): 875-882
Baggio, A.; Montoya, L.; Masaguer, A. 2002: Potencialidad del timbo (Ateleia glazioveana) y el marica (Mimosa bimucronata) para la produccion de biomasa verde en zonas de clima subtropical. I: Persistencia y productividad. Investigacion Agraria Produccion y Proteccion Vegetales 17(1): 101-112
Baggio, A.; Carpanezzi, A.; Masaguer, A. 2002: Potencialidad del timbo (Ateleia glazioveana) y el marica (Mimosa bimucronata) para la produccion de biomasa verde en zonas de clima subtropical. II: Descomposicion y calidad. Investigacion Agraria Produccion y Proteccion Vegetales 17(2): 195-205
Segner, H.; Navas, J.M.; Schäfers, C.; Wenzel, A. 2003: Potencies of estrogenic compounds in in vitro screening assays and in life cycle tests with zebrafish in vivo. Ecotoxicology and Environmental Safety 54(3): 315-322
Bryan-Lluka, L.J.; Siebert, G.A.; Pond, S.M. 1999: Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn-Schmiedeberg's Archives of Pharmacology 360(2): 109-115
Jones, R., N.; Pfaller, M., A. 2000: Potencies of newer fluoroquinolones against Viridans group streptococci isolated in 637 cases of bloodstream infection in the SENTRY antimicrobial surveillance program (1997 to 1999): Beyond Canada!. Antimicrobial Agents and Chemotherapy 44(10): 2922-2923
Potters, L.; Torre, T.; Fearn, P.A.; Leibel, S.A.; Kattan, M.W. 2001: Potency after permanent prostate brachytherapy for localized prostate cancer. International Journal of Radiation Oncology Biology Physics 50(5): 1235-1242
Johnson, D.M.; Biedenbach, D.J.; Jones, R.N. 2002: Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): Emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections. Diagnostic Microbiology and Infectious Disease 43(1): 49-60
D'Amours, M.R.; Granovsky, A.E.; Artemyev, N.O.; Cote, R.H. 1999: Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme. Molecular Pharmacology 55(3): 508-514
Vazeux, G.; Cotton, J.; Cuniasse, P.; Dive, V. 2001: Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme. Biochemical Pharmacology 61(7): 835-841
Guay, J.; Falgueyret, J.P.; Ducret, A.; Percival, M.D.; Mancini, J.A. 2000: Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. European Journal of Biochemistry 267(20): 6311-6318
Kurucz, I.án.; Tóth, S.; Németh, K.ár.; Török, K.; Csillik-Perczel, V.; Pataki, A.; Salamon, C.; Nagy, Z.án.; Székely, J.óz.I.; Horváth, K.; Bodor, N. 2003: Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166). Journal of Pharmacology and Experimental Therapeutics 307(1): 83-92
Calnan, D.P.; Fagbemi, A.; Berlanga-Acosta, J.; Marchbank, T.; Sizer, T.; Lakhoo, K.; Edwards, A.D.; Playford, R.J. 2000: Potency and stability of C terminal truncated human epidermal growth factor. Gut 47(5): 622-627
Lowry, D.W.; Mirakhur, R.K.; Carroll, M.T.; McCarthy, G.J.; Hughes, D.A.; O'Hare, R.A. 1999: Potency and time course of mivacurium block during sevoflurane, isoflurane and intravenous anesthesia. Canadian Journal of Anaesthesia 46(1): 29-33
Marcovistz, R.; Matos, D.C.S.; Georgini, R.A.; Sakauchi, D. 2002: Potency control of diphtheria component in adsorbed vaccines by in vitro neutralization tests. Biologicals: Journal of the International Association of Biological Standardization 30(2): 105-112
Hubbard, A.R.; Bevan, S.A.; Weller, L.J. 2001: Potency estimation of recombinant factor VIII: Effect of assay method and standard. British Journal of Haematology 113(2): 533-536
Premalatha, B.; Sachdanandam, P. 2000: Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B(1)-induced hepatocarcinogenesis: reflection on microsomal biotransformation enzymes. Pharmacological Research 42(2): 161-166
Ugozzoli, M.; Santos, G.; Donnelly, J.; O'Hagan, D.T. 2001: Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant. Journal of Infectious Diseases 183(2): 351-354
Vladimirov, M.; Nau, C.; Mok, W.M.; Strichartz, G. 2000: Potency of bupivacaine stereoisomers tested in vitro and in vivo: biochemical, electrophysiological, and neurobehavioral studies. Anesthesiology 93(3): 744-755
Paoletti, L.C. 2001: Potency of clinical group B streptococcal conjugate vaccines. Vaccine 19(15-16): 2118-2126
Oganesian, A.; Hendricks, J.D.; Pereira, C.B.; Orner, G.A.; Bailey, G.S.; Williams, D.E. 1999: Potency of dietary indole-3-carbinol as a promoter of aflatoxin B1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis 20(3): 453-458
Rosenkilde, M.M.; Schwartz, T.W. 2000: Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor. Molecular Pharmacology 57(3): 602-609
Zhu, X.; Winawer, J.A.; Wallman, J. 2003: Potency of myopic defocus in spectacle lens compensation. IOVS Investigative Ophthalmology and Visual Science 44(7): 2818-2827
King, R.W.; Klabe, R.M.; Reid, C.D.; Erickson-Viitanen, S.K. 2002: Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors. Antimicrobial Agents and ChemoTherapy 46(6): 1640-1646
McMahon, L.R.; Gerak, L.R.; France, C.P. 2001: Potency of positive gamma-aminobutyric acid(A) modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys. Journal of Pharmacology and Experimental Therapeutics 298(3): 1227-1235
Skovmand, O.; Thiery, I.; Benzon, G.L.; Sinègre, G.; Monteny, N.; Becker, N. 1998: Potency of products based on Bacillus thuringiensis var. israelensis: interlaboratory variations. Journal of the American Mosquito Control Association 14(3): 298-304
Johnston, T.P.; Nguyen, L.B.; Chu, W.A.; Shefer, S. 2001: Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis. International Journal of Pharmaceutics 229(1-2): 75-86
Till, M.; Riebniger, D.; Schmitz, H.J.; Schrenk, D. 1999: Potency of various polycyclic aromatic hydrocarbons as inducers of CYP1A1 in rat hepatocyte cultures. Chemico-Biological Interactions 117(2): 135-150
Wilder, R.B.; Chou, R.H.; Ryu, J.K.; Stern, R.L.; Wong, M.S.; Ji, M.; Roach, M.; White, R.D. 2000: Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results. American Journal of Clinical Oncology 23(4): 330-333
Mantz, C.A.; Nautiyal, J.; Awan, A.; Kopnick, M.; Ray, P.; Kandel, G.; Niederberger, C.; Ignacio, L.; Dawson, E.; Fields, R.; Weichselbaum, R.; Vijayakumar, S. 1999: Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors. Cancer Journal From Scientific American 5(4): 230-236
Taffs, R.E. 2001: Potency tests of combination vaccines. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 33(Suppl 4): S362-S366
ElSohly, M.A.; Ross, S.A.; Mehmedic, Z.; Arafat, R.; Yi, B.; Banahan, B.F. 2000: Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997. Journal of Forensic Sciences 45(1): 24-30
Doggrell, S.A.; Chen, Y.Y. 2001: Potency, affinity constants and receptor reserves for noradrenaline and adrenaline on aortae from aged normo- and hypertensive rats. Journal of Pharmacy and Pharmacology 53(2): 205-212
Catalona, W.J.; Carvalhal, G.F.; Mager, D.E.; Smith, D.S. 1999: Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. Journal of Urology 162(2): 433-438
Khawplod, P.; Wilde, H.; Tantawichien, T.; Limusanno, S.; Tantawichien, T.; Mitmoonpitak, C.; Saikasem, A.; Raksakert, S. 2002: Potency, sterility and immunogenicity of rabies tissue culture vaccine after reconstitution and refrigerated storage for 1 week. Vaccine 20(17-18): 2240-2242
Barouch, D.H.; Santra, S.; Tenner-Racz, K.; Racz, P.; Kuroda, M.J.; Schmitz, J.E.; Jackson, S.S.; Lifton, M.A.; Freed, D.C.; Perry, H.C.; Davies, M.-E.; Shiver, J.W.; Letvin, N.L. 2002: Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. Journal of Immunology 168(2): 562-568
Yu, D.; Zhu, F-Gang.; Bhagat, L.; Wang, H.; Kandimalla, E.R.; Zhang, R.; Agrawal, S. 2002: Potent CpG oligonucleotides containing phosphodiester linkages: In vitro and in vivo immunostimulatory properties. Biochemical and Biophysical Research Communications 297(1): 83-90
Ishikawa, Y.; Yamakawa, N.; Uno, T. 2002: Potent DNA photocleavage by zinc(II) complexes of cationic bis-porphyrins linked with aliphatic diamine. Bioorganic and Medicinal Chemistry 10(6): 1953-1960
Li, P.; Zhang, M.; Long, Y.Qiu.; Peach, M.L.; Liu, H.; Yang, D.; Nicklaus, M.; Roller, P.P. 2003: Potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics. Bioorganic and Medicinal Chemistry Letters 13(13): 2173-2177
Rocheblave, L.; Priem, G.; De-Michelis, C.; Kraus, J.L. 1999: Potent HIV protease inhibitors containing a novel (2-phenylsulfanyl-1-hydroxyethyl)amide isostere. Tetrahedron Letters 40(22): 4173-4176
Yao, W.; Chao, M.; Wasserman, Z.R.; Liu, R.Q.; Covington, M.B.; Newton, R.; Christ, D.; Wexler, R.R.; Decicco, C.P. 2002: Potent P1' biphenylmethyl substituted aggrecanase inhibitors. Bioorganic and Medicinal Chemistry Letters 12(1): 101-104, 7 January
Malmsjö, M.; Hou, M.; Pendergast, W.; Erlinge, D.; Edvinsson, L. 2003: Potent P2Y6 receptor mediated contractions in human cerebral arteries. Bmc Pharmacology 3: 4
Hamad, A.R.; O'Herrin, S.M.; Lebowitz, M.S.; Srikrishnan, A.; Bieler, J.; Schneck, J.; Pardoll, D. 1998: Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. Journal of Experimental Medicine 188(9): 1633-1640
Kim, E.S.; Serur, A.; Huang, J.; Manley, C.A.; McCrudden, K.W.; Frischer, J.S.; Soffer, S.Z.; Ring, L.; New, T.; Zabski, S.; Rudge, J.S.; Holash, J.; Yancopoulos, G.D.; Kandel, J.J.; Yamashiro, D.J. 2002: Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America 99(17): 11399-11404
Guillou, C.; Mary, A.; Renko, D.Z.; Gras, E.; Thal, C. 2000: Potent acetylcholinesterase inhibitors: Design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts. Bioorganic and Medicinal Chemistry Letters 10(7): 637-639
Maggio, R.; Scarselli, M.; Novi, F.; Millan, M.J.; Corsini, G.U. 2003: Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. Journal of Neurochemistry 87(3): 631-641
Woo, L.L.; Purohit, A.; Malini, B.; Reed, M.J.; Potter, B.V. 2000: Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Chemistry and Biology 7(10): 773-791
Sturmhoefel, K.; Lee, K.; Gray, G.S.; Thomas, J.; Zollner, R.; O'Toole, M.; Swiniarski, H.; Dorner, A.; Wolf, S.F. 1999: Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant. Cancer Research 59(19): 4964-4972
Ara, G.; Baher, A.; Storm, N.; Horan, T.; Baikalov, C.; Brisan, E.; Camacho, R.; Moore, A.; Goldman, H.; Kohno, T.; Cattley, R.C.; Van, G.; Gaida, K.; Zhang, M.; Whoriskey, J.S.; Fong, D.; Yoshinaga, S.K. 2003: Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts. International Journal of Cancer 103(4): 501-507
Tellander, A.C.; Michaëlsson, E.; Brunmark, C.; Andersson, M. 2000: Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma. Journal of Autoimmunity 14(4): 295-302
Wikberg-Matsson, A.; Simonsen, U. 2001: Potent alpha(2A)-adrenoceptor-mediated vasoconstriction by brimonidine in porcine ciliary arteries. IOVS Investigative Ophthalmology and Visual Science 42(9): 2049-2055
Yang, Z.; Batra, R.; Floyd, D.L.; Hung, H.C.; Chang, G.G.; Tong, L. 2000: Potent and competitive inhibition of malic enzymes by lanthanide ions. Biochemical and Biophysical Research Communications 274(2): 440-444
Rivier, J.; Gulyas, J.; Kirby, D.; Low, W.; Perrin, M.H.; Kunitake, K.; DiGruccio, M.; Vaughan, J.; Reubi, J.C.; Waser, B.; Koerber, S.C.; Martinez, V.; Wang, L.; Taché, Y.; Vale, W. 2002: Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists. Journal of Medicinal Chemistry 45(21): 4737-4747
Augeri, D.J.; Janowick, D.; Kalvin, D.; Sullivan, G.; Larsen, J.; Dickman, D.; Ding, H.; Cohen, J.; Lee, J.; Warner, R.; Kovar, P.; Cherian, S.; Saeed, B.; Zhang, H.; Tahir, S.; Ng, S.C.; Sham, H.; Rosenberg, S.H. 1999: Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase. Bioorganic and Medicinal Chemistry Letters 9(8): 1069-1074
Raatikainen, M.J.; Morey, T.E.; Druzgala, P.; Milner, P.; Gonzalez, M.D.; Dennis, D.M. 2000: Potent and reversible effects of ATI-2001 on atrial and atrioventricular nodal electrophysiological properties in guinea pig isolated perfused heart. Journal of Pharmacology and Experimental Therapeutics 295(2): 779-785
Morimoto, H.; Shimadzu, H.; Kushiyama, E.; Kawanishi, H.; Hosaka, T.; Kawase, Y.; Yasuda, K.; Kikkawa, K.; Yamauchi-Kohno, R.; Yamada, K. 2001: Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives. Journal of Medicinal Chemistry 44(21): 3355-3368
Cherney, R.J.; Mo, R.; Meyer, D.T.; Wang, L.; Yao, W.; Wasserman, Z.R.; Liu, R-Qin.; Covington, M.B.; Tortorella, M.D.; Arner, E.C.; Qian, M.; Christ, D.D.; Trzaskos, J.M.; Newton, R.C.; Magolda, R.L.; Decicco, C.P. 2003: Potent and selective aggrecanase inhibitors containing cyclic P1 substituents. Bioorganic and Medicinal Chemistry Letters 13(7): 1297-1300
Bachand, B.; Tarazi, M.; St-Denis, Y.; Edmunds, J.J.; Winocour, P.D.; Leblond, L.; Siddiqui, M.A. 2001: Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: Transition state inhibitors. Bioorganic and Medicinal Chemistry Letters 11(3): 287-290
Plummer, Janet, S.; Berryman, Kent, A.; Cai, Cuiman; Cody, Wayne, L.; Dimaio, John; Doherty, Annette, M.; Edmunds, Jeremy, J.; He, John, X.; Holland, Debra, R.; Levesque, Sophie; Kent, Darin, R.; Narasimhan, Lakshmi, S.; Rubin, J. Ronald; Rapundalo, Stephen, T.; Siddiqui, M. Arshad; Susser, Alan, J.; St-Denis, Yves; Wincour, Peer, D. 1998: Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications. Bioorganic and Medicinal Chemistry Letters 8(23): 3409-3414
Plummer, J.S.; Berryman, K.A.; Cai, C.; Cody, W.L.; DiMaio, J.; Doherty, A.M.; Edmunds, J.J.; He, J.X.; Holland, D.R.; Levesque, S.; Kent, D.R.; Narasimhan, L.S.; Rubin, J.R.; Rapundalo, S.T.; Siddiqui, M.A.; Susser, A.J.; St-Denis, Y.; Winocour, P.D. 1999: Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications. Bioorganic and Medicinal Chemistry Letters 8(23): 3409-3414
Pikul, S.; Ohler, N.E.; Ciszewski, G.; Laufersweiler, M.C.; Almstead, N.G.; De, B.; Natchus, M.G.; Hsieh, L.C.; Janusz, M.J.; Peng, S.X.; Branch, T.M.; King, S.L.; Taiwo, Y.O.; Mieling, G.E. 2001: Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases. Journal of Medicinal Chemistry 44(16): 2499-2502
James, I.E.; Marquis, R.W.; Blake, S.M.; Hwang, S.M.; Gress, C.J.; Ru, Y.; Zembryki, D.; Yamashita, D.S.; McQueney, M.S.; Tomaszek, T.A.; Oh, H.J.; Gowen, M.; Veber, D.F.; Lark, M.W. 2001: Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro. Journal of Biological Chemistry 276(15): 11507-11511
Candelore, M.R.; Deng, L.; Tota, L.; Guan, X.M.; Amend, A.; Liu, Y.; Newbold, R.; Cascieri, M.A.; Weber, A.E. 1999: Potent and selective human beta(3)-adrenergic receptor antagonists. Journal of Pharmacology and Experimental Therapeutics 290(2): 649-655
Stevens, W.C.; Jones, R.M.; Subramanian, G.; Metzger, T.G.; Ferguson, D.M.; Portoghese, P.S. 2000: Potent and selective indolomorphinan antagonists of the kappa-opioid receptor. Journal of Medicinal Chemistry 43(14): 2759-2769
Stroup, G.B.; Lark, M.W.; Veber, D.F.; Bhattacharyya, A.; Blake, S.; Dare, L.C.; Erhard, K.F.; Hoffman, S.J.; James, I.E.; Marquis, R.W.; Ru, Y.; Vasko-Moser, J.A.; Smith, B.R.; Tomaszek, T.; Gowen, M. 2001: Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 16(10): 1739-1746
Biron, K.K.; Harvey, R.J.; Chamberlain, S.C.; Good, S.S.; Smith, A.A.; Davis, M.G.; Talarico, C.L.; Miller, W.H.; Ferris, R.; Dornsife, R.E.; Stanat, S.C.; Drach, J.C.; Townsend, L.B.; Koszalka, G.W. 2002: Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrobial Agents and ChemoTherapy 46(8): 2365-2372
Sun, J.; Pons, J.; Craik, C.S. 2003: Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies. Biochemistry 42(4): 892-900
Abe, I.; Seki, T.; Noguchi, H. 2000: Potent and selective inhibition of squalene epoxidase by synthetic galloyl esters. Biochemical and Biophysical Research Communications 270(1): 137-140
Kawamoto, T.; Kimura, H.; Kusumoto, K.; Fukumoto, S.; Shiraishi, M.; Watanabe, T.; Sawada, H. 2001: Potent and selective inhibition of the human Na+/H+ exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559. European Journal of Pharmacology 420(1): 1-8
McGuigan, C.; Yarnold, C.J.; Jones, G.; Velázquez, S.; Barucki, H.; Brancale, A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. 1999: Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base. Journal of Medicinal Chemistry 42(22): 4479-4484
Matsuno, K.; Ichimura, M.; Nakajima, T.; Tahara, K.; Fujiwara, S.; Kase, H.; Ushiki, J.; Giese, N.A.; Pandey, A.; Scarborough, R.M.; Lokker, N.A.; Yu, J-Chen.; Irie, J.; Tsukuda, E.; Ide, S-ichi.; Oda, S.; Nomoto, Y. 2002: Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 1. Synthesis, structure-activity relationship, and biological effects of a new class of quinazoline derivatives. Journal of Medicinal Chemistry 45(14): 3057-3066
De Lombaert, S.; Blanchard, L.; Stamford, L.B.; Tan, J.; Wallace, E.M.; Satoh, Y.; Fitt, J.; Hoyer, D.; Simonsbergen, D.; Moliterni, J.; Marcopoulos, N.; Savage, P.; Chou, M.; Trapani, A.J.; Jeng, A.Y. 2000: Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action. Journal of Medicinal Chemistry 43(3): 488-504
Lee, D.; Long, S.A.; Murray, J.H.; Adams, J.L.; Nuttall, M.E.; Nadeau, D.P.; Kikly, K.; Winkler, J.D.; Sung, C.M.; Ryan, M.D.; Levy, M.A.; Keller, P.M.; DeWolf, W.E. 2001: Potent and selective nonpeptide inhibitors of caspases 3 and 7. Journal of Medicinal Chemistry 44(12): 2015-2026
Lee, D.; Long, S.A.; Adams, J.L.; Chan, G.; Vaidya, K.S.; Francis, T.A.; Kikly, K.; Winkler, J.D.; Sung, C.M.; Debouck, C.; Richardson, S.; Levy, M.A.; DeWolf, W.E.; Keller, P.M.; Tomaszek, T.; Head, M.S.; Ryan, M.D.; Haltiwanger, R.C.; Liang, P.H.; Janson, C.A.; McDevitt, P.J.; Johanson, K.; Concha, N.O.; Chan, W.; Abdel-Meguid, S.S.; Badger, A.M.; Lark, M.W.; Nadeau, D.P.; Suva, L.J.; Gowen, M.; Nuttall, M.E. 2000: Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. Journal of Biological Chemistry 275(21): 16007-16014
Bednarek, M.A.; MacNeil, T.; Tang, R.; Kalyani, R.N.; Van der Ploeg, L.H.; Weinberg, D.H. 2001: Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. Biochemical and Biophysical Research Communications 286(3): 641-645
Dumont, Y.; Cadieux, A.; Doods, H.; Fournier, A.; Quirion, R. 2000: Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Canadian Journal of Physiology and Pharmacology 78(2): 116-125
Newton, D.L.; Hansen, H.J.; Mikulski, S.M.; Goldenberg, D.M.; Rybak, S.M. 2001: Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma. Blood 97(2): 528-535
Coburn, G.A.; Cullen, B.R. 2002: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. Journal of Virology 76(18): 9225-9231
Allen, J.D.; van Loevezijn, A.; Lakhai, J.M.; van der Valk, M.; van Tellingen, O.; Reid, G.; Schellens, J.H.M.; Koomen, G-Jan.; Schinkel, A.H. 2002: Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Molecular Cancer Therapeutics 1(6): 417-425
Quinto, I.; Mallardo, M.; Baldassarre, F.; Scala, G.; Englund, G.; Jeang, K.T. 1999: Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development. Journal of Biological Chemistry 274(25): 17567-17572
Bymaster, F.P.; Falcone, J.F.; Bauzon, D.; Kennedy, J.S.; Schenck, K.; Delapp, N.W.; Cohen, M.L. 2001: Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine. European Journal of Pharmacology 430(2-3): 341-349
De-Zwart, Maarten; Vollinga, Roel, C.; Beukers, Margot, W.; Sleegers, Danielle, F.; Von-Frijtag-Drabbe-Kunzel, Jacobien, K.; De-Groote, Miriam; Ijzerman, Ad, P. 1999: Potent antagonists for the human adenosine A2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity. Drug Development Research 48(3): 95-103
Walsh, T.F.; Toupence, R.B.; Young, J.R.; Huang, S.X.; Ujjainwalla, F.; DeVita, R.J.; Goulet, M.T.; Wyvratt, M.J.; Fisher, M.H.; Lo, J.L.; Ren, N.; Yudkovitz, J.B.; Yang, Y.T.; Cheng, K.; Smith, R.G. 2000: Potent antagonists of gonadotropin releasing hormone receptors derived from quinolone-6-carboxamides. Bioorganic and Medicinal Chemistry Letters 10(5): 443-447
Witvrouw, M.; Weigold, H.; Pannecouque, C.; Schols, D.; De Clercq, E.; Holan, G. 2000: Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action. Journal of Medicinal Chemistry 43(5): 778-783
Ono, K.; Yoshiike, Y.; Takashima, A.; Hasegawa, K.; Naiki, H.; Yamada, M. 2003: Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer's disease. Journal of Neurochemistry 87(1): 172-181
O'Keefe, B.R.; Smee, D.F.; Turpin, J.A.; Saucedo, C.J.; Gustafson, K.R.; Mori, T.; Blakeslee, D.; Buckheit, R.; Boyd, M.R. 2003: Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrobial Agents and ChemoTherapy 47(8): 2518-2525
Griggs, J.; Brindle, K.M.; Metcalfe, J.C.; Hill, S.A.; Smith, G.A.; Beauregard, D.A.; Hesketh, R. 2001: Potent anti-metastatic activity of combretastatin-A4. International Journal of Oncology 19(4): 821-825
De Luca, A.; Giancola, M.L.; Ammassari, A.; Grisetti, S.; Cingolani, A.; Larussa, D.; Alba, L.; Murri, R.; Ippolito, G.; Cauda, R.; Monforte, A.; Antinori, A. 2001: Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: Extended follow-up of an observational study. Journal of Neurovirology 7(4): 364-368
Abdel-Hafez, A.A.; Meselhy, M.R.; Nakamura, N.; Hattori, M.; Watanabe, H.; Mohamed, T.A.; Mahfouz, N.M.; el-Gendy, M.A. 1998: Potent anticonvulsant paeonimetabolin-i derivatives obtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis. Chemical and Pharmaceutical Bulletin 46(9): 1486-1487
Kumar, K.; Nguyen, K.; Waxman, S.; Nearing, B.D.; Wellenius, G.A.; Zhao, S.X.; Verrier, R.L. 2003: Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. Journal of the American College of Cardiology 41(10): 1831-1837
Quartaroli, M.; Carignani, C.; Dal Forno, G.; Mugnaini, M.; Ugolini, A.; Arban, R.; Bettelini, L.; Maraia, G.; Belardetti, F.; Reggiani, A.; Trist, D.G.; Ratti, E.; Di Fabio, R.; Corsi, M. 1999: Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. Journal of Pharmacology and Experimental Therapeutics 290(1): 158-169
Tsuchida, S.; Miyazaki, Y.; Matsusaka, T.; Hunley, T.E.; Inagami, T.; Fogo, A.; Ichikawa, I. 1999: Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature. Kidney International 56(2): 509-516
Otoguro, K.; Kohana, A.; Manabe, C.; Ishiyama, A.; Ui, H.; Shiomi, K.; Yamada, H.; Omura, S. 2001: Potent antimalarial activities of polyether antibiotic, X-206. Journal of Antibiotics 54(8): 658-663
Kikuchi, H.; Tasaka, H.; Hirai, S.; Takaya, Y.; Iwabuchi, Y.; Ooi, H.; Hatakeyama, S.; Kim, H-Sook.; Wataya, Y.; Oshima, Y. 2002: Potent antimalarial febrifugine analogues against the Plasmodium malaria parasite. Journal of Medicinal Chemistry 45(12): 2563-2570
Endoh, T.; Matsuura, H.; Tajima, A.; Izumimoto, N.; Tajima, C.; Suzuki, T.; Saitoh, A.; Suzuki, T.; Narita, M.; Tseng, L.; Nagase, H. 1999: Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist. Life Sciences 65(16): 1685-1694
Johnson, M.K.; Alexander, K.E.; Lindquist, N.; Loo, G. 1999: Potent antioxidant activity of a dithiocarbamate-related compound from a marine hydroid. Biochemical Pharmacology 58(8): 1313-1319
Esaki, H.; Kawakishi, S.; Inoue, T.; Osawa, T. 2001: Potent antioxidative o-dihydroxyisoflavones in soybean pastes and their antioxidative activities. Nippon Shokuhin Kagaku Kogaku Kaishi 48(1): 51-57
Heaton, V.J.; Ambler, J.E.; Fisher, L.M. 2000: Potent antipneumococcal activity of gemifloxacin is associated with dual targeting of gyrase and topoisomerase IV, an in vivo target preference for gyrase, and enhanced stabilization of cleavable complexes in vitro. Antimicrobial Agents and ChemoTherapy 44(11): 3112-3117
Notermans, D.W.; de Jong, J.J.; Goudsmit, J.; Bakker, M.; Roos, M.T.; Nijholt, L.; Cremers, J.; Hellings, J.A.; Danner, S.A.; de Ronde, A. 2001: Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. Aids Research and Human Retroviruses 17(11): 1003-1008
Zaunders, J.J.; Cunningham, P.H.; Kelleher, A.D.; Kaufmann, G.R.; Jaramillo, A.B.; Wright, R.; Smith, D.; Grey, P.; Vizzard, J.; Carr, A.; Cooper, D.A. 1999: Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia. Journal of Infectious Diseases 180(2): 320-329
De Cesare, M.; Pratesi, G.; Perego, P.; Carenini, N.; Tinelli, S.; Merlini, L.; Penco, S.; Pisano, C.; Bucci, F.; Vesci, L.; Pace, S.; Capocasa, F.; Carminati, P.; Zunino, F. 2001: Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin. Cancer Research 61(19): 7189-7195
Yamori, T.; Matsunaga, A.; Sato, S.; Yamazaki, K.; Komi, A.; Ishizu, K.; Mita, I.; Edatsugi, H.; Matsuba, Y.; Takezawa, K.; Nakanishi, O.; Kohno, H.; Nakajima, Y.; Komatsu, H.; Andoh, T.; Tsuruo, T. 1999: Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Research 59(16): 4042-4049
Kongkathip, N.; Kongkathip, B.; Siripong, P.; Sangma, C.; Luangkamin, S.; Niyomdecha, M.; Pattanapa, S.; Piyaviriyagul, S.; Kongsaeree, P. 2003: Potent antitumor activity of synthetic 1,2-naphthoquinones and 1,4-naphthoquinones. Bioorganic and Medicinal Chemistry 11(14): 3179-3191
You, S.A.; Basu, A.; Haldar, S. 1999: Potent antitumor agent proteasome inhibitors: a novel trigger for Bcl2 phosphorylation to induce apoptosis. International Journal of Oncology 15(4): 625-628
Miura, S.; Endo, Y.; Yoshimura, Y.; Endo, M.; Yonemura, Y.; Sasaki, T. 2002: Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers. Oncology Reports 9(6): 1319-1322
Loskog, A.; Björkland, A.; Brown, M.P.; Korsgren, O.; Malmström, P.U.; Tötterman, T.H. 2001: Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer. Journal of Urology 166(3): 1093-1097
Charles, M.; Martin, B.; Ginies, C.; Etievant, P.; Coste, G.; Guichard, E. 2000: Potent aroma compounds of two red wine vinegars. Journal of Agricultural and Food Chemistry 48(1): 70-77
Inui, T.; Oshida, T.; Endo, T.; Matsushita, T. 1999: Potent bacteriolytic activity of ritipenem associated with a characteristic profile of affinities for penicillin-binding proteins of Haemophilus influenzae. Antimicrobial Agents and ChemoTherapy 43(10): 2534-2537
Steinmetzer, T.; Zhu, B.Y.; Konishi, Y. 1999: Potent bivalent thrombin inhibitors: replacement of the scissile peptide bond at P(1)-P(1)' with arginyl ketomethylene isosteres. Journal of Medicinal Chemistry 42(16): 3109-3115
Atabey, N.; Gao, Y.; Yao, Z.J.; Breckenridge, D.; Soon, L.; Soriano, J.V.; Burke, T.R.; Bottaro, D.P. 2001: Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. Journal of Biological Chemistry 276(17): 14308-14314
Kapsali, T.; Permutt, S.; Laube, B.; Scichilone, N.; Togias, A. 2000: Potent bronchoprotective effect of deep inspiration and its absence in asthma. Journal of Applied Physiology 89(2): 711-720
Malejka-Giganti, D.; Niehans, G.A.; Reichert, M.A.; Bennett, K.K.; Bliss, R.L. 1999: Potent carcinogenicity of 2,7-dinitrofluorene, an environmental pollutant, for the mammary gland of female Sprague-Dawley rats. Carcinogenesis 20(10): 2017-2023
Conseil, Gëlle.; Perez-Victoria, Jé.M.; Renoir, J.Michel.; Goffeau, Aé.; Di Pietro, A. 2003: Potent competitive inhibition of drug binding to the Saccharomyces cerevisiae ABC exporter Pdr5p by the hydrophobic estradiol-derivative RU49953. Biochimica et Biophysica Acta 1614(2): 131-134
Meerts, I.A.; van Zanden, J.J.; Luijks, E.A.; van Leeuwen-Bol, I.; Marsh, G.; Jakobsson, E.; Bergman, A.; Brouwer, A. 2000: Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicological Sciences: An Official Journal of the Society of Toxicology 56(1): 95-104
Boström, A.; Lindman, H.; Swartling, C.; Berne, B.; Bergh, J. 2001: Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: Results from a double-blind, randomized study. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 59(3): 257-265
Yamasaki, M.; Chujo, H.; Koga, Y.; Oishi, A.; Rikimaru, T.; Shimada, M.; Sugimachi, K.; Tachibana, H.; Yamada, K. 2002: Potent cytotoxic effect of the trans10, cis12 isomer of conjugated linoleic acid on rat hepatoma dRLh-84 cells. Cancer Letters 188(1-2): 171-180
Balboni, G.; Salvadori, S.; Guerrini, R.; Negri, L.; Giannini, E.; Jinsmaa, Y.; Bryant, S.D.; Lazarus, L.H. 2002: Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. Journal of Medicinal Chemistry 45(25): 5556-5563
Knudsen, L.B.; Nielsen, P.F.; Huusfeldt, P.O.; Johansen, N.L.; Madsen, K.; Pedersen, F.Z.; Thøgersen, H.; Wilken, M.; Agersø, H. 2000: Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. Journal of Medicinal Chemistry 43(9): 1664-1669
Mcdonald, H.A.; Chu, K.L.; Bianchi, B.R.; Mckenna, D.G.; Briggs, C.A.; Burgard, E.C.; Lynch, K.J.; Faltynek, C.; Cartmell, J.; Jarvis, M.F. 2002: Potent desensitization of human P2X3 receptors by diadenosine polyphosphates. European Journal of Pharmacology 435(2-3): 135-142
Kitamura, S.; Fukushi, H.; Miyawaki, T.; Kawamura, M.; Konishi, N.; Terashita, Z.; Naka, T. 2001: Potent dibasic GPIIb/IIIa antagonists with reduced prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine derivatives. Journal of Medicinal Chemistry 44(15): 2438-2450
Sciorra, V.A.; Hammond, S.M.; Morris, A.J. 2001: Potent direct inhibition of mammalian phospholipase D isoenzymes by calphostin-c. Biochemistry 40(8): 2640-2646
D'Cruz, O.J.; Dong, Y.; Uckun, F.M. 2003: Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase. Biochemical and Biophysical Research Communications 302(2): 253-264
Sudo, T.; Tachibana, K.; Toga, K.; Tochizawa, S.; Inoue, Y.; Kimura, Y.; Hidaka, H. 2000: Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochemical Pharmacology 59(4): 347-356
Endo, Y.; IIjima, T.; Yamakoshi, Y.; Fukasawa, H.; Miyaura, C.; Inada, M.; Kubo, A.; Itai, A. 2001: Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters. Chemistry and Biology 8(4): 341-355
van der Vliet HJ; Nishi, N.; Koezuka, Y.; von Blomberg BM; van den Eertwegh AJ; Porcelli, S.A.; Pinedo, H.M.; Scheper, R.J.; Giaccone, G. 2001: Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. Journal of Immunological Methods 247(1-2): 61-72
Chitte, R.R.; Dey, S. 2000: Potent fibrinolytic enzyme from a thermophilic Streptomyces megasporus strain SD5. Letters in Applied Microbiology 31(6): 405-410
Moon, I.J.; Choi, K.; Choi, Y.K.; Kim, J.E.; Lee, Y.; Schreiber, A.D.; Park, J.G. 2000: Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1. Journal of Biological Chemistry 275(7): 4647-4653
Kagechika, H.; Komoda, M.; Fujimoto, Y.; Koiso, Y.; Takayama, H.; Kadoya, S.; Miyata, K.; Kato, F.; Kato, M.; Hashimoto, Y. 1999: Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion. Biological and Pharmaceutical Bulletin 22(9): 1010-1012
Lapenta, C.; Santini, S.M.; Logozzi, M.; Spada, M.; Andreotti, M.; Di Pucchio, T.; Parlato, S.; Belardelli, F. 2003: Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha. Journal of Experimental Medicine 198(2): 361-367
Wyant, T.L.; Tanner, M.K.; Sztein, M.B. 1999: Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infection and Immunity 67(3): 1338-1346
Hill, M.E.; Ferguson, D.J.; Austyn, J.M.; Newsom-Davis, J.; Willcox, H.N. 1999: Potent immunostimulatory dendritic cells can be cultured in bulk from progenitors in normal infant and adult myasthenic human thymus. Immunology 97(2): 325-332
Armstrong, H.M.; Wong, F.; Holmes, M.A.; Sinclair, P.J.; Goulet, M.T.; Dumont, F.J.; Staruch, M.J.; Koprak, S.; Peterson, L.B.; Rosa, R.; Wilusz, M.B.; Wiederrecht, G.J.; Cryan, J.G.; Wyvratt, M.J.; Parsons, W.H. 1999: Potent immunosuppressive C32-O-arylethyl ether derivatives of ascomycin with reduced toxicity. Bioorganic and Medicinal Chemistry Letters 9(14): 2089-2094
Spencer, J.V.; Lockridge, K.M.; Barry, P.A.; Lin, G.; Tsang, M.; Penfold, M.E.T.; Schall, T.J. 2002: Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. Journal of Virology 76(3): 1285-1292
Gill, J., K.; Wang, L.; Bretner, M.; Newman, R.; Kyprianou, N.; Hosmane, R., S. 2001: Potent in vitro anticancer activities of ring-expanded (fat) nucleosides containing the imidazo(4,5-e)(1,3)diazepine ring system. Nucleosides Nucleotides and Nucleic Acids 20(4-7): 1043-1045
Hoemann, M.Z.; Kumaravel, G.; Xie, R.L.; Rossi, R.F.; Meyer, S.; Sidhu, A.; Cuny, G.D.; Hauske, J.R. 2000: Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives. Bioorganic and Medicinal Chemistry Letters 10(23): 2675-2678
Hoemann, M.Z.; Xie, R.L.; Rossi, R.F.; Meyer, S.; Sidhu, A.; Cuny, G.D.; Hauske, J.R. 2002: Potent in vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)tetrahydroquinoline derivatives. Bioorganic and Medicinal Chemistry Letters 12(2): 129-132
Radulescu, R.T.; Jaques, G. 2003: Potent in vivo antineoplastic activity of MCR peptides MCR-4 and MCR-14 against chemotherapy-resistant human small cell lung cancer. Drugs under Experimental and Clinical Research 29(2): 69-74
Betz, U.A.K.; Fischer, Rüdiger.; Kleymann, G.; Hendrix, M.; Rübsamen-Waigmann, H. 2002: Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrobial Agents and ChemoTherapy 46(6): 1766-1772
Abe, M.; Shintani, Y.; Eto, Y.; Harada, K.; Kosaka, M.; Matsumoto, T. 2002: Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells. Journal of Leukocyte Biology 72(2): 347-352
Brooks, J.D.; Paton, V.G.; Vidanes, G. 2001: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 10(9): 949-954
Toldbod, H.E.; Agger, R.; Bolund, L.; Hokland, M. 2003: Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols. Scandinavian Journal of Immunology 58(1): 43-50
Shin, J.G.; Kane, K.; Flockhart, D.A. 2001: Potent inhibition of CYP2D6 by haloperidol metabolites: Stereoselective inhibition by reduced haloperidol. British Journal of Clinical Pharmacology 51(1): 45-52
Pham, X.H.; Tuteja, N. 2002: Potent inhibition of DNA unwinding and ATPase activities of pea DNA helicase 45 by DNA-binding agents. Biochemical and Biophysical Research Communications 294(2): 334-339
Yao, Z.J.; King, C.R.; Cao, T.; Kelley, J.; Milne, G.W.; Voigt, J.H.; Burke, T.R. 1999: Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. Journal of Medicinal Chemistry 42(1): 25-35
Trevillyan, J.M.; Chiou, X.G.; Chen, Y.W.; Ballaron, S.J.; Sheets, M.P.; Smith, M.L.; Wiedeman, P.E.; Warrior, U.; Wilkins, J.; Gubbins, E.J.; Gagne, G.D.; Fagerland, J.; Carter, G.W.; Luly, J.R.; Mollison, K.W.; Djuric, S.W. 2001: Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds. Journal of Biological Chemistry 276(51): 48118-48126
Brosh, R.M.; Karow, J.K.; White, E.J.; Shaw, N.D.; Hickson, I.D.; Bohr, V.A. 2000: Potent inhibition of Werner and Bloom helicases by DNA minor groove binding drugs. Nucleic Acids Research 28(12): 2420-2430
McNaughton, N.C.; Warre, R.; Cooper, D.G.; Nasir, S.; Ranson, J.L.; Randall, A. 2000: Potent inhibition of a recombinant low voltage-activated Ca(2+) channel by SB-209712. European Journal of Pharmacology 407(1-2): 53-60
Piossek, C.; Thierauch, K.-H.; Schneider-Mergener, J.; Volkmer-Engert, R.; Bachmann, M.F.; Korff, T.; Augustin, H.G.; Germeroth, L. 2003: Potent inhibition of angiogenesis by D,L-peptides derived from vascular endothelial growth factor receptor 2. Thrombosis and Haemostasis 90(3): 501-510
Prehn, J.L.; Landers, C.; Muller, G.W.; Man, H.W.; Stirling, D.I.; Targan, S.R. 2001: Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues. Journal of Clinical Immunology 21(5): 357-364
Griffin, M.D.; Lutz, W.H.; Phan, V.A.; Bachman, L.A.; McKean, D.J.; Kumar, R. 2000: Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochemical and Biophysical Research Communications 270(3): 701-708
Kester, M.H.; Bulduk, S.; Tibboel, D.; Meinl, W.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.; Bergman, A.; Safe, S.H.; Kuiper, G.G.; Schuur, A.G.; Brouwer, A.; Visser, T.J. 2000: Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141(5): 1897-1900
Kester, M.H.A.; Bulduk, S.; van Toor, H.; Tibboel, D.; Meinl, W.; Glatt, H.; Falany, C.N.; Coughtrie, M.W.H.; Schuur, A.G.; Brouwer, A.; Visser, T.J. 2002: Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. Journal of Clinical Endocrinology and Metabolism 87(3): 1142-1150
Liekens, S.; Verbeken, E.; De Clercq, E.; Neyts, J. 2001: Potent inhibition of hemangiosarcoma development in mice by cidofovir. International Journal of Cancer 92(2): 161-167
Browning, C.M.; Cagnon, L.; Good, P.D.; Rossi, J.; Engelke, D.R.; Markovitz, D.M. 1999: Potent inhibition of human immunodeficiency virus type 1 (HIV-1) gene expression and virus production by an HIV-2 tat activation-response RNA decoy. Journal of Virology 73(6): 5191-5195
Mautino, M.R.; Morgan, R.A. 2000: Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNA. Human Gene Therapy 11(14): 2025-2037
Joshi, P.; Prasad, V.R. 2002: Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). Journal of Virology 76(13): 6545-6557
Atigadda, V.R.; Brouillette, W.J.; Duarte, F.; Ali, S.M.; Babu, Y.S.; Bantia, S.; Chand, P.; Chu, N.; Montgomery, J.A.; Walsh, D.A.; Sudbeck, E.A.; Finley, J.; Luo, M.; Air, G.M.; Laver, G.W. 1999: Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. Journal of Medicinal Chemistry 42(13): 2332-2343
Cho, M.Kyung.; Park, J.Weon.; Jang, Y.Pyo.; Kim, Y.Choong.; Kim, S.Geon. 2002: Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappa Balpha phosphorylation and of p65 nuclear translocation in macrophages. International Immunopharmacology 2(1): 105-116
Oikawa, H.; Yagi, K.; Ohashi, S.; Watanabe, K.; Mie, T.; Ichihara, A.; Honma, M.; Kobayashi, K. 2000: Potent inhibition of macrophomate synthase by reaction intermediate analogs. Bioscience Biotechnology and Biochemistry 64(11): 2368-2379
Russo, N.; Shapiro, R. 1999: Potent inhibition of mammalian ribonucleases by 3', 5'-pyrophosphate-linked nucleotides. Journal of Biological Chemistry 274(21): 14902-14908
Njar, V.C.; Nnane, I.P.; Brodie, A.M. 2000: Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids. Bioorganic and Medicinal Chemistry Letters 10(17): 1905-1908
Smith, B.D.; Soellner, M.B.; Raines, R.T. 2003: Potent inhibition of ribonuclease a by oligo(vinylsulfonic acid). Journal of Biological Chemistry 278(23): 20934-20938
Ciobanu, L.C.; Boivin, R.P.; Luu-The, V.; Labrie, F.; Poirier, D. 1999: Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol. Journal of Medicinal Chemistry 42(12): 2280-2286
Gowan, S.M.; Heald, R.; Stevens, M.F.; Kelland, L.R. 2001: Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Molecular Pharmacology 60(5): 981-988
Bachmann, A.; Russ, U.; Quast, U. 1999: Potent inhibition of the CFTR chloride channel by suramin. Naunyn-Schmiedeberg's Archives of Pharmacology 360(4): 473-476
Kumar, G.N.; Dykstra, J.; Roberts, E.M.; Jayanti, V.K.; Hickman, D.; Uchic, J.; Yao, Y.; Surber, B.; Thomas, S.; Granneman, G.R. 1999: Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: a positive drug-drug interaction. Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(8): 902-908
Murakami, S.; Lefebvre, V.; de Crombrugghe, B. 2000: Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. Journal of Biological Chemistry 275(5): 3687-3692
Li, C.J.; Li, Y.Z.; Pinto, A.V.; Pardee, A.B. 1999: Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints. Proceedings of the National Academy of Sciences of the United States of America 96(23): 13369-13374
Nguyen, D.N.; Stump, C.A.; Walsh, E.S.; Fernandes, C.; Davide, J.P.; Ellis-Hutchings, M.; Robinson, R.G.; Williams, T.M.; Lobell, R.B.; Huber, H.E.; Buser, C.A. 2002: Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic and Medicinal Chemistry Letters 12(9): 1269-1273
Shen, W.; Fakhoury, S.; Donner, G.; Henry, K.; Lee, J.; Zhang, H.; Cohen, J.; Warner, R.; Saeed, B.; Cherian, S.; Tahir, S.; Kovar, P.; Bauch, J.; Ng, S.C.; Marsh, K.; Sham, H.; Rosenberg, S. 1999: Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacements. Bioorganic and Medicinal Chemistry Letters 9(5): 703-708
Damianaki, A.; Bakogeorgou, E.; Kampa, M.; Notas, G.; Hatzoglou, A.; Panagiotou, S.; Gemetzi, C.; Kouroumalis, E.; Martin, P.M.; Castanas, E. 2000: Potent inhibitory action of red wine polyphenols on human breast cancer cells. Journal of Cellular Biochemistry 78(3): 429-441
Liang, S.L.; Pan, J.T. 2001: Potent inhibitory effect of selective D2 and D3 agonists on dopamine-responsive dorsomedial arcuate neurons in brain slices of estrogen-primed rats. Life Sciences 69(22): 2653-2662
Hart, C.P.; Martin, J.E.; Reed, M.A.; Keval, A.A.; Pustelnik, M.J.; Northrop, J.P.; Patel, D.V.; Grove, J.R. 1999: Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries. Cellular Signalling 11(6): 453-464
Le, N.T.V.; Richardson, D.R. 2003: Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. Carcinogenesis 24(6): 1045-1058
Vamecq, J.; Maurois, P.; Bac, P.; Bailly, F.; Bernier, J-Luc.; Stables, J.P.; Husson, I.; Gressens, P. 2003: Potent mammalian cerebroprotection and neuronal cell death inhibition are afforded by a synthetic antioxidant analogue of marine invertebrate cell protectant ovothiols. European Journal of Neuroscience 18(5): 1110-1120
Singh, L.K.; Boucher, W.; Pang, X.; Letourneau, R.; Seretakis, D.; Green, M.; Theoharides, T.C. 1999: Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. Journal of Pharmacology and Experimental Therapeutics 288(3): 1349-1356
Koya, R.C.; Kasahara, N.; Favaro, P.M.B.; Lau, R.; Ta, H.Q.; Weber, J.S.; Stripecke, R. 2003: Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery. Journal of ImmunoTherapy 26(5): 451-460
von Moltke, L.L.; Durol, A.L.; Duan, S.X.; Greenblatt, D.J. 2000: Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole. European Journal of Clinical Pharmacology 56(3): 259-261
Pacher, Pál.; Liaudet, L.; Bai, Péter.; Mabley, J.G.; Kaminski, P.M.; Virág, László.; Deb, A.; Szabó, E.; Ungvári, Zán.; Wolin, M.S.; Groves, J.T.; Szabó, C. 2003: Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction. Circulation 107(6): 896-904
Basolo, F.; Giannini, R.; Monaco, C.; Melillo, R.M.; Carlomagno, F.; Pancrazi, M.; Salvatore, G.; Chiappetta, G.; Pacini, F.; Elisei, R.; Miccoli, P.; Pinchera, A.; Fusco, A.; Santoro, M. 2002: Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma. American Journal of Pathology 160(1): 247-254
Hanasaki, K.; Yamada, K.; Yamamoto, S.; Ishimoto, Y.; Saiga, A.; Ono, T.; Ikeda, M.; Notoya, M.; Kamitani, S.; Arita, H. 2002: Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation. Journal of Biological Chemistry 277(32): 29116-29124
Grünblatt, E.; Mandel, S.; Gassen, M.; Youdim, M.B. 1999: Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity. Journal of Neural Transmission. Supplementum 55: 57-70
Chyan, Y.J.; Poeggeler, B.; Omar, R.A.; Chain, D.G.; Frangione, B.; Ghiso, J.; Pappolla, M.A. 1999: Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. Journal of Biological Chemistry 274(31): 21937-21942
Xu, W.; Smith-Franklin, B.A.; Li, P.L.; Wood, C.; He, J.; Du, Q.; Bhat, G.J.; Kankasa, C.; Katinger, H.; Cavacini, L.A.; Posner, M.R.; Burton, D.R.; Chou, T.C.; Ruprecht, R.M. 2001: Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. Journal of Human Virology 4(2): 55-61
Walker, B.; Darkins, P.A.; McKervey, M.A.; Moncrieff, H.M.; Lynas, J.F. 2000: Potent new leucine aminopeptidase inhibitor of novel structure synthesised by a modified Wadsworth-Emmons (Horner) Wittig procedure. Bioorganic and Medicinal Chemistry Letters 10(13): 1481-1482
Ashton, W.T.; Sisco, R.M.; Yang, Y.T.; Lo, J.L.; Yudkovitz, J.B.; Gibbons, P.H.; Mount, G.R.; Ren, R.N.; Butler, B.S.; Cheng, K.; Goulet, M.T. 2001: Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus. Bioorganic and Medicinal Chemistry Letters 11(13): 1727-1731
Zhang, J.; Didierlaurent, S.; Fortin, M.; Lefrançois, D.; Uridat, E.; Vevert, J.P. 2000: Potent nonpeptide endothelin antagonists: Synthesis and structure-activity relationships of pyrazole-5-carboxylic acids. Bioorganic and Medicinal Chemistry Letters 10(22): 2575-2578
Zhang, P.; Terefenko, E.A.; Fensome, A.; Zhang, Z.; Zhu, Y.; Cohen, J.; Winneker, R.; Wrobel, J.; Yardley, J. 2002: Potent nonsteroidal progesterone receptor agonists: Synthesis and SAR study of 6-aryl benzoxazines. Bioorganic and Medicinal Chemistry Letters 12(5): 787-790
Triqui, R.; Guth, H. 2001: Potent odorants in Smen, a traditional fermented butter product. European Food Research and Technology 212(3): 292-295
Mutti, B.; Grosch, W. 1999: Potent odorants of boiled potatoes. Nahrung 43(5): 302-306
Czerny, M.; Grosch, W. 2000: Potent odorants of raw Arabica coffee. Their changes during roasting. Journal of Agricultural and Food Chemistry 48(3): 868-872
Josef, K.A.; Kauer, F.W.; Bihovsky, R. 2001: Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain i. Bioorganic and Medicinal Chemistry Letters 11(19): 2615-2617
Fujimoto, T.; Nakamura, T.; Ikeda, T.; Takagi, K. 2000: Potent protective effects of melatonin on experimental spinal cord injury. Spine 25(7): 769-775
Myers, M.R.; He, W.; Hanney, B.; Setzer, N.; Maguire, M.P.; Zulli, A.; Bilder, G.; Galzcinski, H.; Amin, D.; Needle, S.; Spada, A.P. 2003: Potent quinoxaline-based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR exploration effective bioisosteric replacement of a phenyl substituent. Bioorganic and Medicinal Chemistry Letters 13(18): 3091-3095, 15 September
He, W.; Myers, M.R.; Hanney, B.; Spada, A.P.; Bilder, G.; Galzcinski, H.; Amin, D.; Needle, S.; Page, K.; Jayyosi, Z.; Perrone, M.H. 2003: Potent quinoxaline-based inhibitors of PDGF receptor tyrosine kinase activity. Part 2: The synthesis and biological activities of RPR127963 an orally bioavailable inhibitor. Bioorganic and Medicinal Chemistry Letters 13(18): 3097-3100
Urbanek, R.A.; Suchard, S.J.; Steelman, G.B.; Knappenberger, K.S.; Sygowski, L.A.; Veale, C.A.; Chapdelaine, M.J. 2001: Potent reversible inhibitors of the protein tyrosine phosphatase CD45. Journal of Medicinal Chemistry 44(11): 1777-1793
Roush, W.R.; Cheng, J.; Knapp-Reed, B.; Alvarez-Hernandez, A.; McKerrow, J.H.; Hansell, E.; Engel, J.C. 2001: Potent second generation vinyl sulfonamide inhibitors of the Trypanosomal cysteine protease cruzain. Bioorganic and Medicinal Chemistry Letters 11(20): 2759-2762
Burgess, L.E.; Newhouse, B.J.; Ibrahim, P.; Rizzi, J.; Kashem, M.A.; Hartman, A.; Brandhuber, B.J.; Wright, C.D.; Thomson, D.S.; Vigers, G.P.; Koch, K. 1999: Potent selective nonpeptidic inhibitors of human lung tryptase. Proceedings of the National Academy of Sciences of the United States of America 96(15): 8348-8352
Nisijima, K.; Yoshino, T.; Yui, K.; Katoh, S. 2001: Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Research 890(1): 23-31
Bhardwaj, A.; Sawada, M.; London, E.D.; Koehler, R.C.; Traystman, R.J.; Kirsch, J.R. 1998: Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke 29(11): 2404
Lai, J.Y.Q.; Cox, P.J.; Patel, R.; Sadiq, S.; Aldous, D.J.; Thurairatnam, S.; Smith, K.; Wheeler, D.; Jagpal, S.; Parveen, S.; Fenton, G.; Harrison, T.K.P.; McCarthy, C.; Bamborough, P. 2003: Potent small molecule inhibitors of spleen tyrosine kinase (Syk). Bioorganic and Medicinal Chemistry Letters 13(18): 3111-3114
Rivier, J.E.; Hoeger, C.; Erchegyi, J.; Gulyas, J.; DeBoard, R.; Craig, A.G.; Koerber, S.C.; Wenger, S.; Waser, B.; Schaer, J.C.; Reubi, J.C. 2001: Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1). Journal of Medicinal Chemistry 44(13): 2238-2246
Anderson, J.; Banerjea, A.; Planelles, V.; Akkina, R. 2003: Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. Aids Research and Human Retroviruses 19(8): 699-706
Mattingly, R.R.; Gibbs, R.A.; Menard, R.E.; Reiners, J.J. 2002: Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase. Journal of Pharmacology and Experimental Therapeutics 303(1): 74-81
Fan, S.L.; Schroeder, N.J.; Calverley, M.J.; Burrin, J.M.; Makin, H.L.; Cunningham, J. 2000: Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2). Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 15(12): 1943-1949
Yang, B.; Gao, L.; Li, L.; Lu, Z.; Fan, X.; Patel, C.A.; Pomerantz, R.J.; DuBois, G.C.; Zhang, H. 2002: Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins. Journal of Biological Chemistry 278(8): 6596-6602
Jarvest, R.L.; Berge, J.M.; Brown, P.; Hamprecht, D.W.; Mcnair, D.J.; Mensah, L.; O'hanlon, P.J.; Pope, A.J. 2001: Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383. Bioorganic and Medicinal Chemistry Letters 11(5): 715-718
Fu, X.; Zhang, X. 2002: Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. Cancer Research 62(8): 2306-2312
Medina-Gomez, G.; Hernàndez, A.; Calvo, R.-M.; Martin, E.; Obregón, M.-J. 2003: Potent thermogenic action of triiodothyroacetic acid in brown adipocytes. Cellular and Molecular Life Sciences: Cmls 60(9): 1957-1967
Nantermet, P.G.; Selnick, H.G. 2003: Potent thrombin inhibitors via a 20-membered ring olefin metathesis macrocyclization. Tetrahedron Letters 44(11): 2401-2404, 10 March
Pollack, I.F.; Erff, M.; Bom, D.; Burke, T.G.; Strode, J.T.; Curran, D.P. 1999: Potent topoisomerase i inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo. Cancer Research 59(19): 4898-4905
Sakabe, K.; Teramoto, H.; Zohar, M.; Behbahani, B.; Miyazaki, H.; Chikumi, H.; Gutkind, J.S. 2002: Potent transforming activity of the small GTP-binding protein Rit in NIH 3T3 cells: evidence for a role of a p38gamma-dependent signaling pathway. Febs Letters 511(1-3): 15-20
Carlier, P.R.; Du, D.M.; Han, Y.; Liu, J.; Pang, Y.P. 1999: Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors. Bioorganic and Medicinal Chemistry Letters 9(16): 2335-2338
Vasudevan, A.; Qian, Y.; Vogt, A.; Blaskovich, M.A.; Ohkanda, J.; Sebti, S.M.; Hamilton, A.D. 1999: Potent, highly selective, and non-thiol inhibitors of protein geranylgeranyltransferase-i. Journal of Medicinal Chemistry 42(8): 1333-1340
Chen, Y.K.; Lin, H.C.; Liu, J.C.; Wan, F.J. 2001: Potent, hydroxyl radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum. Brain Research 896(1-2): 165-168
Chackalamannil, S.; Doller, D.; Eagen, K.; Czarniecki, M.; Ahn, H.S.; Foster, C.J.; Boykow, G. 2001: Potent, low molecular weight thrombin receptor antagonists. Bioorganic and Medicinal Chemistry Letters 11(21): 2851-2853
Kline, T.; Andersen, N.H.; Harwood, E.A.; Bowman, J.; Malanda, A.; Endsley, S.; Erwin, A.L.; Doyle, M.; Fong, S.; Harris, A.L.; Mendelsohn, B.; Mdluli, K.; Raetz, C.R.H.; Stover, C.K.; Witte, P.R.; Yabannavar, A.; Zhu, S. 2002: Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC. Journal of Medicinal Chemistry 45(14): 3112-3129
de Laszlo, S.E.; Hacker, C.; Li, B.; Kim, D.; MacCoss, M.; Mantlo, N.; Pivnichny, J.V.; Colwell, L.; Koch, G.E.; Cascieri, M.A.; Hagmann, W.K. 1999: Potent, orally absorbed glucagon receptor antagonists. Bioorganic and Medicinal Chemistry Letters 9(5): 641-646
Wang, L.; Woods, K.W.; Li, Q.; Barr, K.J.; McCroskey, R.W.; Hannick, S.M.; Gherke, L.; Credo, R.Bruce.; Hui, Y-Hua.; Marsh, K.; Warner, R.; Lee, J.Y.; Zielinski-Mozng, N.; Frost, D.; Rosenberg, S.H.; Sham, H.L. 2002: Potent, orally active heterocycle-based combretastatin A-4 analogues: Synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. Journal of Medicinal Chemistry 45(8): 1697-1711
Pasternak, A.; Pan, Y.; Marino, D.; Sanderson, P.E.; Mosley, R.; Rohrer, S.P.; Birzin, E.T.; Huskey, S.E.; Jacks, T.; Schleim, K.D.; Cheng, K.; Schaeffer, J.M.; Patchett, A.A.; Yang, L. 1999: Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization. Bioorganic and Medicinal Chemistry Letters 9(3): 491-496
Patterson, L.J.; Malkevitch, N.; Zhao, J.; Peng, B.; Robert-Guroff, M. 2002: Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef. Dna and Cell Biology 21(9): 627-635
Patterson, L.Jean.; Malkevitch, N.; Pinczewski, J.; Venzon, D.; Lou, Y.; Peng, B.; Munch, C.; Leonard, M.; Richardson, E.; Aldrich, K.; Kalyanaraman, V.S.; Pavlakis, G.N.; Robert-Guroff, M. 2003: Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120. Journal of Virology 77(16): 8607-8620
Mathvink, R.J.; Tolman, J.S.; Chitty, D.; Candelore, M.R.; Cascieri, M.A.; Colwell, L.F.; Deng, L.; Feeney, W.P.; Forrest, M.J.; Hom, G.J.; MacIntyre, D.E.; Tota, L.; Wyvratt, M.J.; Fisher, M.H.; Weber, A.E. 2000: Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore. Bioorganic and Medicinal Chemistry Letters 10(17): 1971-1973
Malamas, M., S.; Largis, E.; Gunawan, I.; Li, Z.; Tillett, J.; Han, S.-Ching-Hsien; Mulvey, R. 2000: Potent, selective aminothiazolidinediones agonists of the human beta3 adrenergic receptor. Medicinal Chemistry Research 10(3): 164-177
Mathvink, R.J.; Barritta, A.M.; Candelore, M.R.; Cascieri, M.A.; Deng, L.; Tota, L.; Strader, C.D.; Wyvratt, M.J.; Fisher, M.H.; Weber, A.E. 1999: Potent, elective human beta3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore. Bioorganic and Medicinal Chemistry Letters 9(13): 1869-1874
Xin, Z.; Oost, T.K.; Abad-Zapatero, C.; Hajduk, P.J.; Pei, Z.; Szczepankiewicz, B.G.; Hutchins, C.W.; Ballaron, S.J.; Stashko, M.A.; Lubben, T.; Trevillyan, J.M.; Jirousek, M.R.; Liu, G. 2003: Potent, selective inhibitors of protein tyrosine phosphatase 1B. Bioorganic and Medicinal Chemistry Letters 13(11): 1887-1890
Costanzo, M.J.; Yabut, S.C.; Almond, H.R.; Andrade-Gordon, P.; Corcoran, T.W.; De Garavilla, L.; Kauffman, J.A.; Abraham, W.M.; Recacha, R.; Chattopadhyay, D.; Maryanoff, B.E. 2003: Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. Journal of Medicinal Chemistry 46(18): 3865-3876
Wapstra, E.; O'reilly, J.M. 2001: Potential 'costs of reproduction' in a skink: Inter- and intrapopulational variation. Australian Journal of Ecology 26(2): 179-186
Majali, M.A.; Saxena, S.K.; Joshi, S.H.; Unni, P.R.; Ramamoorthy, N. 2001: Potential 166Ho radiopharmaceuticals for endovascular radionuclide therapy. II. Preparation and evaluation of 166Ho-DTPA. Nuclear Medicine Communications 22(1): 97-103
Bonasera, T.A.; Ortu, G.; Rozen, Y.; Krais, R.; Freedman, N.M.; Chisin, R.; Gazit, A.; Levitzki, A.; Mishani, E. 2001: Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase. Nuclear Medicine and Biology 28(4): 359-374
Harimaya, Y.; Koizumi, K.; Andoh, T.; Nojima, H.; Kuraishi, Y.; Saiki, I. 2002: Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Letters 187(1-2): 121-127
Orio, F.J.; Terouanne, B.; Georget, V.; Lumbroso, S.; Avances, C.; Siatka, C.; Sultan, C. 2002: Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines. Molecular and Cellular Endocrinology 198(1-2): 105-114
Mattern-Dogru, E.; Ma, X.; Hartmann, J.; Decker, H.; Stöckigt, J. 2002: Potential active-site residues in polyneuridine aldehyde esterase, a central enzyme of indole alkaloid biosynthesis, by modelling and site-directed mutagenesis. European Journal of Biochemistry 269(12): 2889-2896
Melki, S.A.; Safar, A.; Martin, J.; Ivanova, A.; Adi, M. 1999: Potential acuity pinhole: a simple method to measure potential visual acuity in patients with cataracts, comparison to potential acuity meter. Ophthalmology 106(7): 1262-1267
Webster, R.G. 1999: Potential advantages of DNA immunization for influenza epidemic and pandemic planning. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(2): 225-229
Spiker, E.C.; Emptage, R.E.; Giannamore, M.R.; Pedersen, C.A. 2001: Potential adverse drug events in an indigent and homeless geriatric population. Annals of PharmacoTherapy 35(10): 1166-1172
Zini, A.; Mak, V.; Phang, D.; Jarvi, K. 1999: Potential adverse effect of semen processing on human sperm deoxyribonucleic acid integrity. Fertility and Sterility 72(3): 496-499
Kelly, H.William.; Nelson, H.S. 2003: Potential adverse effects of the inhaled corticosteroids. Journal of Allergy and Clinical Immunology 112(3): 469-78; quiz 479
Dubey, K.; Balani, D.K.; Pillai, K.K. 2003: Potential adverse interaction between aspirin and Lisinopril in hypertensive rats. Human and Experimental Toxicology 22(3): 143-147
Zalavras, C.; Dailiana, Z.; Elisaf, M.; Bairaktari, E.; Vlachogiannopoulos, P.; Katsaraki, A.; Malizos, K.N. 2000: Potential aetiological factors concerning the development of osteonecrosis of the femoral head. European Journal of Clinical Investigation 30(3): 215-221
Macias, F.A.; Varela, R.M.; Torres, A.; Molinillo, J.M.G. 2000: Potential allelopathic activity of natural plant heliannanes: A proposal of absolute configuration and nomenclature. Journal of Chemical Ecology 26(9): 2173-2186
Pharand, C.; Palisaitis, D.A.; Hamel, D. 2002: Potential anaphylactic shock with abciximab readministration. Pharmacotherapy 22(3): 380-383
Christensen, Torben-Rojle 1999: Potential and actual trace gas fluxes in Arctic terrestrial ecosystems. Polar Research 18(2): 199-206
Mbuligwe, S.E.; Kassenga, G.R.; Kaseva, M.E.; Chaggu, E.J. 2002: Potential and constraints of composting domestic solid waste in developing countries: Findings from a pilot study in Dar es Salaam, Tanzania. Resources Conservation and Recycling 36(1): 45-59
Lee, J.C.; Kim, J.S.; Kang, I.J.; Cho, M.H.; Park, P.K.; Lee, C.H. 2001: Potential and limitations of alum or zeolite addition to improve the performance of a submerged membrane bioreactor. Water Science and Technology: a Journal of the International Association on Water Pollution Research 43(11): 59-66
Michalke, B. 1999: Potential and limitations of capillary electrophoresis inductively coupled plasma mass spectrometry. Journal of Analytical Atomic Spectrometry 14(9): 1297-1302
Buck, D.; Alber, M.; Nüsslin, F. 2003: Potential and limitations of the automatic detection of fiducial markers using an amorphous silicon flat-panel imager. Physics in Medicine and Biology 48(6): 763-774
Lubeznova, N.V. 2002: Potential and real seed production of Anthoxanthum odoratum L. in alpine communities. Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody, Otdel Biologicheskii 107(5): 40-44
Lemon, G.D.; Posluszny, U.; Husband, B.C. 2001: Potential and realized rates of vegetative reproduction in Spirodela polyrhiza, Lemna minor, and Wolffia borealis. Aquatic Botany 70(1): 79-87
Montrucchio, G.; Sapino, A.; Bussolati, B.; Ghisolfi, G.; Rizea-Savu, S.; Silvestro, L.; Lupia, E.; Camussi, G. 1998: Potential angiogenic role of platelet-activating factor in human breast cancer. American Journal of Pathology 153(5): 1589-1596
Inui, S.; Nakajima, T.; Fukuzato, Y.; Fujimoto, N.; Chang, C.; Yoshikawa, K.; Itami, S. 2001: Potential anti-androgenic activity of roxithromycin in skin. Journal of Dermatological Science 27(2): 147-151
Kłodzińska, A.; Chojnacka-Wójcik, E.; Pałucha, A.; Brański, P.; Popik, P.; Pilc, A. 1999: Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology 38(12): 1831-1839
Wolf, J.E. 2002: Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Advances in Therapy 19(3): 109-118
Dachir, S.; Fishbeine, E.; Meshulam, Y.; Sahar, R.; Amir, A.; Kadar, T. 2002: Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Human and Experimental Toxicology 21(4): 197-203
Sarfraz, T., B.; Husain, S., A.; Murtaza, N.; Siddiqui, B., S. 2000: Potential antibacterial agents Part-V. Synthesis and structural characterization of some new 3-aryl 7H, 6-(aryl) 5H-1, 2,4-triazolo (3,4-b)-1, 3, 5-thiadiazines. Pakistan Journal of Scientific and Industrial Research 43(6): 334-337
Husain, S., A.; Sarfaraz, T., B.; Murtaza, N.; Sultana, N. 2000: Potential antibacterial agents. Part III. Synthesis of 7-oxa-spiro (5,9)pentadecane-1,8,13 trione: A novel macrocyclic lactone. Pakistan Journal of Scientific and Industrial Research 43(3): 180-183
Hussain, S., A.; Sarfaraz, T., B.; Murtaza, N.; Faizi, S. 1998: Potential antibacterial agents. Part-IV. Synthesis of new 1(2-pyrimidino)-amino-methyl benzimidazoles and 1,2,3 benzotriazoles. Pakistan Journal of Scientific and Industrial Research 41(2): 63-67
Lehr, E. 2002: Potential antidepressant properties of pramipexole detected in locomotor and operant behavioral investigations in mice. Psychopharmacology 163(3-4): 495-500
Cordi, A.A.; Berque-Bestel, I.; Persigand, T.; Lacoste, J.M.; Newman-Tancredi, A.; Audinot, V.; Millan, M.J. 2001: Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties. Journal of Medicinal Chemistry 44(5): 787-805
Kulevanova, S.; Kaftandzieva, A.; Dimitrovska, A.; Stefkov, G.; Panovski, N. 2002: Potential antimicrobial activity of the essential oil of some Macedonian Thymus tosevii Vel. (Lamiaceae) varieties. Acta Pharmaceutica 52(4): 305-311
Rupérez, P.; Ahrazem, O.; Leal, J.Antonio. 2002: Potential antioxidant capacity of sulfated polysaccharides from the edible marine brown seaweed Fucus vesiculosus. Journal of Agricultural and Food Chemistry 50(4): 840-845
Miyachi, Y. 2001: Potential antioxidant mechanism of action for metronidazole: Implications for rosacea management. Advances in Therapy 18(6): 237-243
Andersen, M.L.; Outtrup, H.; Skibsted, L.H. 2000: Potential antioxidants in beer assessed by ESR spin trapping. Journal of Agricultural and Food Chemistry 48(8): 3106-3111
Jakobisiak, M.; Golab, J. 2003: Potential antitumor effects of statins (Review). International Journal of Oncology 23(4): 1055-1069
Baker, R.O.; Bray, M.; Huggins, J.W. 2003: Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Research 57(1-2): 13-23
Lussi, C.; Grapengeter, M.; Schuettler, J. 1999: Potential application and value of simulator training in anesthesia. Anaesthesist 48(7): 433-438
Esimone, C.O.; Adikwu, M.U.; Ibezim, E.C.; Ofoefule, S.I.; Nwafor, S.V.; Onuoha, O.M.duka 2002: Potential application of Garcinia kola seed as a natural antidote for the management of ciprofloxacin poisoning: An in vitro study. Acta Pharmaceutica 52(3): 219-226
Parodi, K.; Enghardt, W. 2000: Potential application of PET in quality assurance of proton therapy. Physics in Medicine and Biology 45(11): N151-N156
Radwan, S.S.; Al-Hasan, R.H. 2001: Potential application of coastal biofilm-coated gravel particles for treating oily waste. Aquatic Microbial Ecology 23(2): 113-117
Shilton, A. 2000: Potential application of computational fluid dynamics to pond design. Water Science and Technology 42(10-11): 327-334
Jozwiak, J.; Skopinski, P.; Grzela, T.; Malejczyk, J. 2001: Potential application of cytokine level measurement in corneal epithelium. International Journal of Molecular Medicine 7(6): 665-667
Sawhney, A.K.; Johal, M.S. 1999: Potential application of elemental analysis of fish otoliths as pollution indicator. Bulletin of Environmental Contamination and Toxicology 63(6): 698-702
Bivalacqua, T.J.; Hellstrom, W.J. 2001: Potential application of gene therapy for the treatment of erectile dysfunction. Journal of Andrology 22(2): 183-190
Ghomshei, M.M.; Allen, D.M. 2000: Potential application of oxygen-18 and deuterium in mining effluent and acid rock drainage studies. Environmental Geology 39(7): 767-773
Aisien, F.A.; Hymore, F.K.; Ebewele, R.O. 2003: Potential application of recycled rubber in oil pollution control. Environmental Monitoring and Assessment 85(2): 175-190
Bedouet, L.A.nold, F.B.tina, P.R.breau, G. 1998: Potential application of the Clostridium tyrobutyricum flagellin as substrate for proteinase detection. Biotechnology letters 20(11): 1011-1016
Huelsenbeck, J.P.; Larget, B.; Miller, R.E.; Ronquist, F. 2002: Potential applications and pitfalls of Bayesian inference of phylogeny. Systematic Biology 51(5): 673-688
Dorta, Mía.Jesús.; Santoveña, A.; Llabrés, Mías.; Fariña, Jé.B. 2002: Potential applications of PLGA film-implants in modulating in vitro drugs release. International Journal of Pharmaceutics 248(1-2): 149-156
Pai, S.L.; Chong, N.M.; Chen, C.H. 1999: Potential applications of aerobic denitrifying bacteria as bioagents in waste water treatment. Bioresource Technology 68(2): 179-185
Brawley, J.W.; Brush, M.J.; Kremer, J.N.; Nixon, S.W. 2003: Potential applications of an empirical phytoplankton production model to shallow water ecosystems. Ecological Modelling 160(1-2): 55-61, 1 February
Fried, N.M. 2001: Potential applications of the erbium:YAG laser in endourology. Journal of Endourology 15(9): 889-894
Sheiner, E.K.; Sheiner, E.; Carel, R.; Potashnik, G.; Shoham-Vardi, I. 2002: Potential association between male infertility and occupational psychological stress. Journal of Occupational and Environmental Medicine 44(12): 1093-1099
Hill, E.M.; Stoltenberg, S.F.; Burmeister, M.; Closser, M.; Zucker, R.A. 1999: Potential associations among genetic markers in the serotonergic system and the antisocial alcoholism subtype. Experimental and Clinical Psychopharmacology 7(2): 103-121
Scannapieco, F.A.; Ho, A.W. 2001: Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. Journal of Periodontology 72(1): 50-56
Kalb, J.L.; Marazon, D.J.; Snow, R.J. 2002: Potential barriers to control of blood pressure. Journal of the American Osteopathic Association 102(4): 209-213
Rochetaing, A.; Chapon, C.; Marescaux, L.; Le Bouil, A.; Furber, A.; Kreher, P. 2003: Potential beneficial as well as detrimental effects of chronic treatment with lisinopril and (or) spironolactone on isolated hearts following low-flow ischemia in normal and infarcted rats. Canadian Journal of Physiology and Pharmacology 81(9): 864-872
Pons, G.ér.; Tréluyer, J.-M.; Dimet, J.ér.ôm.; Merlé, Y. 2002: Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates. Therapeutic Drug Monitoring 24(1): 9-14
Stellbrink, C.; Auricchio, A.; Diem, B.; Breithardt, O.A.; Kloss, M.; Schöndube, F.A.; Klein, H.; Messmer, B.J.; Hanrath, P. 1999: Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. American Journal of Cardiology 83(5B): 143D-150D
Piercy, V.; Toseland, C.D.; Turner, N.C. 1998: Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice. Metabolism, Clinical and Experimental 47(12): 1477-1480
Seago, D.P.; Raman, A.; Lele, S. 2001: Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers. Gynecologic Oncology 83(2): 282-285
Tse, K.-C.; Yip, P.-S.; Hui, K.-M.; Li, F.-K.; Yuen, K.-Y.; Lai, K.-N.; Chan, T.-M. 2002: Potential benefit of plasma exchange in treatment of severe icteric leptospirosis complicated by acute renal failure. Clinical and Diagnostic Laboratory Immunology 9(2): 482-484
Peters, H.P.; De Vries, W.R.; Vanberge-Henegouwen, G.P.; Akkermans, L.M. 2001: Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract. Gut 48(3): 435-439
Jost, A.; Junger, A.; Zickmann, B.; Hartmann, B.; Banzhaf, A.; Quinzio, L.; Müller, M.; Wagner, R.M.; Hempelmann, G. 2003: Potential benefits of Anaesthesia Information Management Systems for multicentre data evaluation: risk calculation of inotropic support in patients undergoing cardiac surgery. Medical Informatics and the Internet in Medicine 28(1): 7-19
Lipsitch, M.; Davis, G.; Corey, L. 2002: Potential benefits of a serodiagnostic test for herpes simplex virus type 1 (HSV-1) to prevent neonatal HSV-1 infection. Sexually Transmitted Diseases 29(7): 399-405
Andersson, Karl Erik 2002: Potential benefits of muscarinic M3 receptor selectivity. European Urology Suppls 1(4): 23-28
Utley, M.; Gallivan, S.; Young, A.; Cox, N.; Davies, P.; Dixey, J.; Emery, P.; Gough, A.; James, D.; Prouse, P.; Williams, P.; Winfield, J.; Devlin, J.A. 2000: Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies. Rheumatology 39(1): 1-2
Viles, J.H.; Duggan, B.M.; Zaborowski, E.; Schwarzinger, S.; Huntley, J.J.; Kroon, G.J.; Dyson, H.J.; Wright, P.E. 2001: Potential bias in NMR relaxation data introduced by peak intensity analysis and curve fitting methods. Journal of Biomolecular NMR 21(1): 1-9
Lida, T.; Nakamori, R.; Yabuta, R.; Yada, S.; Takagi, Y.; Mano, N.; Ikegawa, S.; Goto, J.; Nambara, T. 2002: Potential bile acid metabolites. 24. An efficient synthesis of carboxyl-linked glucosides and their chemical properties. Lipids 37(1): 101-110
Iida, T.; Hikosaka, M.; Kakiyama, G.; Shiraishi, K.; Schteingart, C.D.; Hagey, L.R.; Ton-Nu, H.-T.; Hofmann, A.F.; Mano, N.; Goto, J.; Nambara, T. 2002: Potential bile acid metabolites. 25. Synthesis and chemical properties of stereoisomeric 3alpha,7alpha,16- and 3alpha,7alpha,15-trihydroxy-5beta-cholan-24-oic acids. Chemical and Pharmaceutical Bulletin 50(10): 1327-1334
Scott, B.L.; Wang, Z.; Marrone, B.L.; Sauer, N.N. 2003: Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: A combined theoretical and structural database study. Journal of Inorganic Biochemistry 94(1-2): 5-13
D'Acunto, M.Rosa.; Gelfi, C.; Stoyanov, A.; Andreev, V.; Righetti, P.Giorgio. 2002: Potential binding of borate ions to mono- and oligonucleotides: a capillary electrophoresis investigation. Journal of Chromatography A 979(1-2): 285-297
Giudice, L.C. 1999: Potential biochemical markers of uterine receptivity. Human Reproduction 14(Suppl 2): 3-16
Chou, C.L.; Zwicker, B.; Porter, J.F.; Pelletier, G.R. 1999: Potential biofouling strategies against blue mussel (Mytilus edulis) infestation in a cooling water system. Canadian Technical Report of Fisheries and Aquatic Sciences 2283: i-vi, 1-89
Serry, F.M.E.; Kadry, A.A.; Abdelrahman, A.A. 2003: Potential biological indicators for glutaraldehyde and formaldehyde sterilization processes. Journal of Industrial Microbiology and Biotechnology 30(3): 135-140
Yang, S.P.; Woolf, A.S.; Yuan, H.T.; Scott, R.J.; Risdon, R.A.; O'Hare, M.J.; Winyard, P.J. 2000: Potential biological role of transforming growth factor-beta1 in human congenital kidney malformations. American Journal of Pathology 157(5): 1633-1647
Kim, K.A.; Lim, Y.; Kim, J.H.; Kim, E.K.; Chang, H.S.; Park, Y.M.; Ahn, B.Y. 1999: Potential biomarker of coal workers' pneumoconiosis. Toxicology Letters 108(2-3): 297-302
Vidal, M.-L..; Bassères, A.; Narbonne, J.-F.. 2001: Potential biomarkers of trichloroethylene and toluene exposure in Corbicula fluminea. Environmental Toxicology and Pharmacology 9(3): 87-97
Crumpacker, D.W.; Box, E.O.; Hardin, E.D.nnis 2001: Potential breakup of Florida plant communities as a result of climatic warming. Florida Scientist 64(1): 29-43
von Giesen, H-J.; Weiss, P.; Arendt, G.; Hefter, H. 2003: Potential c-fiber damage in Wilson's disease. Acta Neurologica Scandinavica 108(4): 257-261
Ishii, H.; Dumon, K.R.; Vecchione, A.; Fong, L.Y.; Baffa, R.; Huebner, K.; Croce, C.M. 2001: Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. JAMA 286(19): 2441-2449
Vachálková, A.; Eisenreichová, E.; Haladová, M.; Mucaji, P.; Józová, B.; Novotný, L. 2000: Potential carcinogenic and inhibitory activity of compounds isolated from Lilium candidum L. Neoplasma 47(5): 313-318
Dovinová, I.; Vachálková, A.; Novotný, L. 1999: Potential carcinogenicity of some transition metal ions. Biological Trace Element Research 67(1): 63-73
Novotný, L.; Vachálková, A.; Pískala, A. 1999: Potential carcinogenicity of the synthetic 1,3,6-triazine (6-azapyrimidine) nucleic acid analogues determined by DC polarography. II. Nucleosides of 6-azauracil. Neoplasma 46(3): 156-160
Chapman, C.A.; Chapman, L.J.; Kaufman, L.; Zanne, A.E. 1999: Potential causes of arrested succession in Kibale National Park, Uganda: Growth and mortality of seedlings. African Journal of Ecology 37(1): 81-92
Applewhite, A.A.; Wilkens, B.E.; McDonald, D.E.; Radasch, R.M.; Barstad, R.D. 1999: Potential central nervous system complications of von Willebrand's disease. Journal of the American Animal Hospital Association 35(5): 423-429
Loukos, H.; Monfray, P.; Bopp, L.; Lehodey, P. 2003: Potential changes in skipjack tuna (Katsuwonus pelamis) habitat from a global warming scenario: Modelling approach and preliminary results. Fisheries Oceanography 12(4-5): 474-482
Heikoop, J.; Hickmott, D.; Risk, M.; Shearer, C.; Atudorei, V. 2002: Potential climate signals from the deep-sea gorgonian coral Primnoa resedaeformis. Hydrobiologia 1: 117-124
Tentori, L.; Portarena, I.; Graziani, G. 2002: Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacological Research 45(2): 73-85
Gilbert, K.M.; Wahid, R.; Fecher, N.P.; Freeman, J.P.; Fifer, E.K. 2000: Potential clinical use of butyric acid derivatives to induce antigen-specific T cell inactivation. Journal of Pharmacology and Experimental Therapeutics 294(3): 1146-1153
Markman, M.; Kennedy, A.; Kim, J. 2001: Potential clinical utility of CA-125 in responsive but persistent large-volume ovarian cancer following platinum-based chemotherapy. Gynecologic Oncology 83(3): 593-595
Andreani, A.; Leoni, A.; Locatelli, A.; Morigi, R.; Chiericozzi, M.; Fraccari, A.; Galatulas, I. 1998: Potential coanthracyclinic activity of pyridylmethylene-2-indolinones. Anticancer Research 18(5a): 3407-3409
Massei, G.; Lyon, A.; Cowan, D.P. 2003: Potential compounds for inducing conditioned taste aversion in ferrets. New Zealand Journal of Zoology 30(2): 95-100
Glinoer, D. 2001: Potential consequences of maternal hypothyroidism on the offspring: Evidence and implications. Hormone Research 55(3): 109-114
Bender, M.H. 2000: Potential conservation of biomass in the production of synthetic organics. Resources Conservation and Recycling 30(1): 49-58
O'driscoll, R., L.; Schneider, D., C.; Rose, G., A.; Lilly, G., R. 2000: Potential contact statistics for measuring scale-dependent spatial pattern and association: An example of northern cod (Gadus morhua) and capelin (Mallotus villosus). Canadian Journal of Fisheries and Aquatic Sciences 57(7): 1355-1368
Neily, J.B.; Toto, K.H.; Gardner, E.B.; Rame, J.Eduardo.; Yancy, C.W.; Sheffield, M.A.; Dries, D.L.; Drazner, M.H. 2002: Potential contributing factors to noncompliance with dietary sodium restriction in patients with heart failure. American Heart Journal 143(1): 29-33
Taniyama, Y.; Morishita, R.; Nakagami, H.; Moriguchi, A.; Sakonjo, H.; Shokei-Kim; Matsumoto, K.; Nakamura, T.; Higaki, J.; Ogihara, T. 2000: Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102(2): 246-252
Warren Burhenne, L.J.; Wood, S.A.; D'Orsi, C.J.; Feig, S.A.; Kopans, D.B.; O'Shaughnessy, K.F.; Sickles, E.A.; Tabar, L.; Vyborny, C.J.; Castellino, R.A. 2000: Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology 215(2): 554-562
Fukushi, K.; Hiiro, K.; Ishio, N. 1999: Potential contribution of discarded cigarettes to anthropogenic eutrophication in an urban area. Analytical Communications 36(9-10): 345-347
Massey, B.T. 2001: Potential control of gastroesophageal reflux by local modulation of transient lower esophageal sphincter relaxations. American Journal of Medicine 111(Suppl): 186s-189s
Regnier, M.; Duval, C.; Schmidt, R. 1999: Potential cosmetic applications of reconstructed epidermis. International Journal of Cosmetic Science 21(1): 51-58
Hynes, D.M.; Stroupe, K.T.; Greer, J.W.; Reda, D.J.; Frankenfield, D.L.; Kaufman, J.S.; Henderson, W.G.; Owen, W.F.; Rocco, M.V.; Wish, J.B.; Kang, J.; Feussner, J.R. 2002: Potential cost savings of erythropoietin administration in end-stage renal disease. American Journal of Medicine 112(3): 169-175
Blake, G.J.; Ridker, P.M.; Kuntz, K.M. 2003: Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia. American Journal of Medicine 114(6): 485-494
Sanders, G.D.; Hlatky, M.A.; Every, N.R.; McDonald, K.M.; Heidenreich, P.A.; Parsons, L.S.; Owens, D.K. 2001: Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Annals of Internal Medicine 135(10): 870-883
Yu, P.H.; Deng, Y. 2000: Potential cytotoxic effect of chronic administration of creatine, a nutrition supplement to augment athletic performance. Medical Hypotheses 54(5): 726-728
Cerelli, J.S.; Johnson, L. 1999: Potential daily sperm production, sertoli cell number, and seminiferous tubule characteristics in beef bulls fed conventional or gossypol-enriched diets. Journal of Andrology 20(4): 519-528
Muñoz, D.R.; de Almeida, M.; Lopes, E.A.; Iwamura, E.S. 1999: Potential definition of the time of death from autolytic myocardial cells: a morphometric study. Forensic Science International 104(2-3): 81-89
Jan, J.T.; Chen, B.H.; Ma, S.H.; Liu, C.I.; Tsai, H.P.; Wu, H.C.; Jiang, S.Y.; Yang, K.D.; Shaio, M.F. 2000: Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved. Journal of Virology 74(18): 8680-8691
Pinay, G.; O'keefe, T.; Edwards, R.; Naiman, R.J. 2003: Potential denitrification activity in the landscape of a western Alaska drainage basin. Ecosystems 6(4): 336-343
Cattani, M.; Cena, K.; Edwards, J.; Pisaniello, D. 2001: Potential dermal and inhalation exposure to chlorpyrifos in Australian pesticide workers. Annals of Occupational Hygiene 45(4): 299-308
Ward, P.E. 2000: Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders. Prostaglandins Leukotrienes and Essential Fatty Acids 63(1-2): 65-68
Fukuda, Y.; Naganuma, T. 2001: Potential dietary effects on the fatty acid composition of the common jellyfish Aurelia aurita. ine Biology Berlin ; 138(5): 1029-1035
Giraldeau, L.-A.; Valone, T.J.; Templeton, J.J. 2002: Potential disadvantages of using socially acquired information. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 357(1427): 1559-1566
Guzman-Del-Proo, S., A.; Salinas, F.; Zaytsev, O.; Belmar-Perez, J.; Carrillo-Laguna, J. 2000: Potential dispersion of reproductive products and larval stages of abalone (Haliotis spp.) as a function of the hydrodynamics of Bahia Tortugas, Mexico. Journal of Shellfish Research 19(2): 869-881
Bertolla, F.; Kay, E.; Simonet, P. 2000: Potential dissemination of antibiotic resistance genes from transgenic plants to microorganisms. Infection Control and Hospital Epidemiology 21(6): 390-393
Chee, P.A.; Braby, L.A.; Conroy, T.J. 2000: Potential doses to passengers and crew of supersonic transports. Health Physics 79(5): 547-552
Loebstein, R.; Kurnik, D.; Lubetsky, A.; Ezra, D.; Halkin, H. 2003: Potential dosing errors using portable prothrombin time monitoring devices. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(5): 479-483
Johnston, T.P.; Baker, J.C.; Jamal, A.S.; Hall, D.; Emeson, E.E.; Palmer, W.K. 1999: Potential downregulation of HMG-CoA reductase after prolonged administration of P-407 in C57BL/6 mice. Journal of Cardiovascular Pharmacology 34(6): 831-842
Egger, S.S.; Drewe, J.ür.; Schlienger, R.G. 2003: Potential drug-drug interactions in the medication of medical patients at hospital discharge. European Journal of Clinical Pharmacology 58(11): 773-778
Beerheide, W.; Bernard, H.U.; Tan, Y.J.; Ganesan, A.; Rice, W.G.; Ting, A.E. 1999: Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. Journal of the National Cancer Institute 91(14): 1211-1220
Van Asseldonk, M.A.P.M.; Jalvingh, A.W.; Huirne, R.B.M.; Dijkhuizen, A.A. 1999: Potential economic benefits from changes in management via information technology applications on Dutch dairy farms: A simulation study. Livestock Production Science 60(1): 33-44
Chrubasik, S.; Künzel, O.; Black, A.; Conradt, C.; Kerschbaumer, F. 2001: Potential economic impact of using a proprietary willow bark extract in outpatient treatment of low back pain: an open non-randomized study. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 8(4): 241-251
Jacobsen, S.J.; Xia, Z.; Campion, M.E.; Darby, C.H.; Plevak, M.F.; Seltman, K.D.; Melton, L.J. 1999: Potential effect of authorization bias on medical record research. Mayo Clinic Proceedings 74(4): 330-338
Ladabaum, U.; Scheiman, J.M.; Fendrick, A.Mark. 2003: Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: A cost-effectiveness analysis. American Journal of Medicine 114(7): 546-554
X.W.nbin; Liu Weiping; Liu Guangshen 2001: Potential effect of fertilising and tilling on N2O emission from upland soils analyzed by DNDC model. Yingyong Shengtai Xuebao 12(6): 917-922
Hales, S.; de Wet, N.; Maindonald, J.; Woodward, A. 2002: Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 360(9336): 830-834
Patterson, R.; Harris, K.E.; Grammer, L.C.; Greenberger, P.A.; Ditto, A.M.; Shaughnessy, M.A. 1999: Potential effect of the administration of substance P and allergen therapy on immunoglobulin E-mediated allergic reactions in human subjects. Journal of Laboratory and Clinical Medicine 133(2): 189-199
Chikwenhere, G., P.; Vestergaard, S. 2001: Potential effects of Beauveria bassiana (Balsmo) Vuillemin on Neochetina bruchi Hustache (Coleoptera: Curculionidae), a biological control agent of water hyacinth. Biological Control 21(2): 105-110
Moore, M.V.; Zakova, P.; Shaeffer, K.A.; Burton, R.P. 1998: Potential effects of Canada geese and climate change on phosphorus inputs to suburban lakes of the Northeastern U.S.A. Lake and Reservoir Management 14(1): 52-59
Russ, G.R.; Mccook, L.J. 1999: Potential effects of a cyclone on benthic algal production and yield to grazers on coral reefs across the central Great Barrier Reef. Journal of Experimental Marine Biology and Ecology 235(2): 237-254
Jasser, I.; Arvola, L. 2003: Potential effects of abiotic factors on the abundance of autotrophic picoplankton in four boreal lakes. Journal of Plankton Research 25(8): 873-883
Kilgore, J.L.; Ross, C.R.; Saunders, D.K. 2003: Potential effects of anesthetic agents on heat shock proteins in the laboratory rat. Texas Journal of Science 55(2): 149-158
Schulze, T., L.; Jordan, R., A.; Hung, R., W. 2001: Potential effects of animal activity on the spatial distribution of Ixodes scapularis and Amblyomma americanum (Acari: Ixodidae). Environmental Entomology 30(3): 568-577
Damstra, T. 2002: Potential effects of certain persistent organic pollutants and endocrine disrupting chemicals on the health of children. Journal of Toxicology. Clinical Toxicology 40(4): 457-465
Winnett, S.M. 1998: Potential effects of climate change on U.S. forests: A review. Climate Research 11(1): 39-49
Nadkarni, N.M.; Solano, R. 2002: Potential effects of climate change on canopy communities in a tropical cloud forest: An experimental approach. Oecologia (Berlin) 131(4): 580-586
Sorenson, L.G.; Goldberg, R.; Root, T.L.; Anderson, M.G. 1998: Potential effects of global warming on waterfowl populations breeding in the Northern Great Plains. Climatic Change 40(2): 343-369
de Sylva, DP.; Richards, WJ.; Capo, TR.; Serafy, JE. 2000: Potential effects of human activities on billfishes (Istiophoridae and Xiphiidae) in the western Atlantic Ocean. Bulletin of Marine Science 66(1): 187-198
Scott, B.; Marteinsdottir, G.; Wright, P. 1999: Potential effects of maternal factors on spawning stock-recruitment relationships under varying fishing pressure. Canadian Journal of Fisheries and Aquatic Sciences 56(10): 1882-1890
Lydersen, E.; Löfgren, S. 2002: Potential effects of metals in reacidified limed water bodies in Norway and Sweden. Environmental Monitoring and Assessment 73(2): 155-178
Thorp, J., H.; Casper, A., F. 2002: Potential effects on zooplankton from species shifts in planktivorous mussels: A field experiment in the St Lawrence River. Freshwater Biology 47(1): 107-119
Bourre, L.; Thibaut, S.; Briffaud, A.; Lajat, Y.; Patrice, T. 2002: Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract. Pharmacological Research 45(2): 159-165
White, D., J.; Kendall, K.C.; Picton, H.D. 1999: Potential energetic effects of mountain climbers on foraging grizzly bears. Wildlife Society Bulletin 27(1): 146-151
Ohkubo, Y.Z.; Crippen, G.M. 2000: Potential energy function for continuous state models of globular proteins. Journal of Computational Biology: a Journal of Computational Molecular Cell Biology 7(3-4): 363-379
Palmo, K.; Mannfors, B.; Mirkin, N.G.; Krimm, S. 2003: Potential energy functions: from consistent force fields to spectroscopically determined polarizable force fields. Biopolymers 68(3): 383-394
Stortz, C., A.; Cerezo, A., S. 2002: Potential energy surfaces of alpha-(1fwdarw3)-linked disaccharides calculated with the MM3 force-field. Journal of Carbohydrate Chemistry 21(5): 355-371
Ito, M.; Blumberg, B.M.; Mock, D.J.; Goodman, A.D.; Moser, A.B.; Moser, H.W.; Smith, K.D.; Powers, J.M. 2001: Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. Journal of Neuropathology and Experimental Neurology 60(10): 1004-1019
Shen, F.W.; Yu, Y.J.; McKellop, H. 1999: Potential errors in FTIR measurement of oxidation in ultrahigh molecular weight polyethylene implants. Journal of Biomedical Materials Research 48(3): 203-210
Saito, T.; Furukawa, T.; Nanri, S.; Saito, I. 1999: Potential errors resulting from sex and age difference in assessing family history of diabetes. Preventive Medicine 28(1): 33-39
Abul, H.; Mahmoud, F.; Al-Rayes, S.; Al-Khaja, A.; Haines, D.; Omu, A. 2001: Potential etiological involvement of zinc, copper, selenium and magnesium in preeclamptic and hypertensive parturient women in Kuwait. Trace Elements and Electrolytes 18(1): 20-25
Wamala, S.P.; Mittleman, M.A.; Schenck-Gustafsson, K.; Orth-Gomér, K. 1999: Potential explanations for the educational gradient in coronary heart disease: a population-based case-control study of Swedish women. American Journal of Public Health 89(3): 315-321
Garrod, A.N.; Guiver, R.; Rimmer, D.A. 2000: Potential exposure of amateurs (consumers) through painting wood preservative and antifoulant preparations. Annals of Occupational Hygiene 44(6): 421-426
Adamczyk, J., J.,. Jr.;; Sumerford, D., V. 2001: Potential factors impacting season-long expression of Cry1Ac in 13 commercial varieties of Bollgard(R) cotton. Journal of Insect Science 1(Cited Feb 13, 2002): 1-11
Nakajima, F.; Murakami, G.; Ohyama, S.; Horiguchi, T.; Sakakura, Y.; Yajima, T.; Hirata, K. 2001: Potential fascial dome made by the upper leaf of the phreno-esophageal membrane. Okajimas Folia Anatomica Japonica 77(6): 201-209
Osadchuk, L.V. 2001: Potential fertility, mortality of embryos, and fetal vitality in silver foxes (Vulpes vulpes) after long-term selection for domestic behavior. Zoologicheskii Zhurnal 80(7): 864-870
Henery, R.; Farnell, L.; Gibson, W.G.; Bennett, M.R. 2002: Potential fields in vascular smooth muscle generated by transmitter release from sympathetic varicosities. Journal of Theoretical Biology 218(4): 531-548
Dukas, R.; Duan, J.J.n 2000: Potential fitness consequences of associative learning in a parasitoid wasp. Behavioral Ecology 11(5): 536-543
Bolton, M.; Medeiros, R.; Fraga, H. 2001: Potential flight range of Snow Buntings Plectrophenax nivalis occurring in the Azores islands in late March: A first analysis. Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas (18A): 93-95
Nair, D.R.; Morris, H.H. 1999: Potential fluconazole-induced carbamazepine toxicity. Annals of PharmacoTherapy 33(7-8): 790-792
Haugaard, V.K.; Udsen, A.M.; Mortensen, G.; Hoegh, L.; Petersen, K.; Monahan, F. 2001: Potential food applications of biobased materials. An EU-concerted action project. Starch 53(5): 189-200
Arengo, F.; Baldassarre, G.A. 1998: Potential food availability and flamingo use of commercial salt impoundments in the Ria Lagartos Biosphere Reserve, Mexico. Colonial Waterbirds 21(2): 211-221
Apiwathnasor, C.; Prommongkol, S.; Samung, Y.; Limrat, D.; Rojruthai, B. 2002: Potential for Anopheles campestris (Diptera: Culicidae) to transmit malaria parasites in Pa Rai subdistrict (Aranyaprathet, Sa Kaeo Province), Thailand. Journal of Medical Entomology 39(4): 583-586
Agha, S. 2000: Potential for HIV transmission among truck drivers in Pakistan. Aids 14(15): 2404-2406
Stamm, W.E. 2000: Potential for antimicrobial resistance in Chlamydia pneumoniae. Journal of Infectious Diseases 181(Suppl 3): S456-S459
Zhou, H.; Weinberg, C.R. 1999: Potential for bias in estimating human fecundability parameters: A comparison of statistical models. Statistics in Medicine 18(4): 411-422
Klaren, H.M.; van't Veer, L.J.; van Leeuwen, F.E.; Rookus, M.A. 2003: Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. Journal of the National Cancer Institute 95(13): 941-947
Sobolev, B.; Brown, P.; Zelt, D. 2001: Potential for bias in waiting time studies: events between enrolment and admission. Journal of Epidemiology and Community Health 55(12): 891-894
Batten, J.S.; Scholthof, K.B.th G.; Lovic, B.R.; Miller, M.E.; Martyn, R.D. 2000: Potential for biocontrol of Monosporascus root rot/vine decline under greenhouse conditions using hypovirulent isolates of Monosporascus cannonballus. European Journal of Plant Pathology 106(7): 639-649
Jinantana, J.; Sariah, M. 1998: Potential for biological control of Sclerotium foot rot of chilli by Trichoderma spp. Pertanika Journal of Tropical Agricultural Science 21(1): 1-10
Kahn, R.H.; Moseley, K.E.; Johnson, G.; Farley, T.A. 2000: Potential for community-based screening, treatment, and antibiotic prophylaxis for syphilis prevention. Sexually Transmitted Diseases 27(4): 188-192
Tarnopolsky, M.A.; Beal, M.F. 2001: Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Annals of Neurology 49(5): 561-574
Talmadge, J.E.; Singh, R.; Ageitos, A.; Buyukberber, S. 2001: Potential for cytokine and product manipulation to improve the results of autologous stem cell transplantation for rheumatoid arthritis. Journal of Rheumatology. Supplement 64: 32-38
Baker, J.R.; Satarug, S.; Edwards, R.J.; Moore, M.R.; Williams, D.J.; Reilly, P.E.B. 2003: Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity. Toxicology Letters (Shannon) 137(1-2): 85-93, January 31st
Molla, A.H.; Shamsuddin, Z.H.; Halimi, M.S.; Morziah, M.; Puteh, A.B. 2001: Potential for enhancement of root growth and nodulation of soybean coinoculated with Azospirillum and Bradyrhizobium in laboratory systems. Soil Biology and Biochemistry 33(4-5): 457-463
Moriya, F.; Hashimoto, Y. 2001: Potential for error when assessing blood cyanide concentrations in fire victims. Journal of Forensic Sciences 46(6): 1421-1425
Lee, W-Chung.; Ho, Y-Yi. 2003: Potential for gene-gene confounding bias in case-parental control studies. Annals of Epidemiology 13(4): 261-266
Moffatt, S.D.; McAlister, V.; Calne, R.Y.; Metcalfe, S.M. 1999: Potential for improved therapeutic index of FK506 in liposomal formulation demonstrated in a mouse cardiac allograft model. Transplantation 67(9): 1205-1208
Mathevon, N.; Charrier, I.; Jouventin, P. 2003: Potential for individual recognition in acoustic signals: a comparative study of two gulls with different nesting patterns. Comptes Rendus Biologies 326(3): 329-337
Brierley, A.S.; Brandon, M.A. 1999: Potential for long-distance dispersal of Euphausia crystallorophias in fast current jets. Marine Biology (Berlin) 135(1): 77-82
Haasen, C.; Yagdiran, O.; Mass, R.; Krausz, M. 2000: Potential for misdiagnosis among Turkish migrants with psychotic disorders: a clinical controlled study in Germany. Acta Psychiatrica Scandinavica 101(2): 125-129
Bent, E.; Chanway, C.P. 2002: Potential for misidentification of a spore-forming Paenibacillus polymyxa isolate as an endophyte by using culture-based methods. Applied and environmental microbiology 68(9): 4650-4652
Vasseur, L.; Shipley, W.; Ansseau, C. 1999: Potential for municipal sewage sludge application on agricultural lands in southern Quebec. Water Quality Research Journal of Canada 34(3): 469-480
Leakey, R.R.B. 1999: Potential for novel food products from agroforestry trees: A review. Food Chemistry 66(1): 1-14
Johnson, A.; White, C.B.ardwaj, L.J.rgens, M. 2000: Potential for octylphenol to biodegrade in some English rivers. Environmental toxicology and chemistry 00 19(10): 2486-2492
Karim, M.R.; Abbaszadegan, M.; Lechevallier, M. 2003: Potential for pathogen intrusion during pressure transients. Journal - American Water Works Association 95(5): 134-146
Hetherington, N.J.; Dooley, M.J. 2000: Potential for patient harm from intrathecal administration of preserved solutions. Medical Journal of Australia 173(3): 141-143
Barron, M.G.; Ka'aihue, L. 2001: Potential for photoenhanced toxicity of spilled oil in Prince William Sound and Gulf of Alaska waters. Marine Pollution Bulletin 43(1-6): 86-92
Adams, J. 2003: Potential for proteasome inhibition in the treatment of cancer. Drug Discovery Today 8(7): 307-315
Bolla, R.I.; Harms, R.; Kozlowski, P.; Brown, G.; Niblack, T.; Kay, E. 1998: Potential for protection of soybean against soybean cyst nematode through management of the nematode's life cycle: Egg hatching. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 63(2B): 625-633
Fullerton, A., H.; Lamberti, G., A.; Lodge, D., M.; Goetz, F., W. 2000: Potential for resource competition between Eurasian ruffe and yellow perch: Growth and RNA responses in laboratory experiments. Transactions of the American Fisheries Society 129(6): 1331-1339
Armstrong, J.; Hightower, J. 2002: Potential for restoration of the Roanoke River population of Atlantic sturgeon. Journal of Applied Ichthyology 18(4-6): 475-480
Johanning, K.; Stevenson, C.A.án.; Oyeniran, O.O.; Gozal, Y.M.; Roy-Engel, A.M.; Jurka, J.; Deininger, P.L. 2003: Potential for retroposition by old Alu subfamilies. Journal of Molecular Evolution 56(6): 658-664
Archer, J.A.; Richardson, E.C.; Herd, R.M.; Arthur, P.F. 1999: Potential for selection to improve efficiency of feed use in beef cattle: A review. Australian Journal of Agricultural Research 50(2): 147-161
Diggins, T.P.; Baier, R.E.; Meyer, A.E.; Forsberg, R.L. 2002: Potential for selective, controlled biofouling by Dreissena species to intercept pollutants from industrial effluents. Biofouling 18(1): 29-36
Wyatt, C.A.; Coon, C.I.; Gibson, J.J.; Brinckerhoff, C.E. 2002: Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Research 62(24): 7200-7202
Kalpers, J.; Lanjouw, A. 1998: Potential for the creation of a Peace Park in the Virunga Volcano Region. Cahiers d'Ethologie 18(2): 187-206
Rouillon, R.; Boucher, N.; Gingras, Y.; Carpentier, R. 2000: Potential for the use of photosystem II submembrane fractions immobilised in poly(vinylalcohol) to detect heavy metals in solution or in sewage sludge. Journal of Chemical Technology and Biotechnology 75(11): 1003-1007
Juntunen, V.; Neuvonen, S.; Norokorpi, Y.; Tasanen, T. 2002: Potential for timberline advance in northern Finland, as revealed by monitoring during 1983-99. Arctic 55(4): 348-361
Avramescu, A.; Rouillon, R.; Carpentier, R. 1999: Potential for use of a cyanobacterium Synechocystis sp. immobilized in poly(vinylalcohol): Application to the detection of pollutants. Biotechnology Techniques 13(8): 559-562
Halleen, J.M.; Räisänen, S.R.; Alatalo, S.L.; Väänänen, H.K. 2003: Potential function for the ROS-generating activity of TRACP. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 18(10): 1908-1911
Schwarz, P.M.; Kleinert, H.; Förstermann, U. 1999: Potential functional significance of brain-type and muscle-type nitric oxide synthase i expressed in adventitia and media of rat aorta. Arteriosclerosis Thrombosis and Vascular Biology 19(11): 2584-2590
Cohen, S.A.; Trikha, M.; Mascelli, M.A. 2000: Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications. Pathology Oncology Research: Por 6(3): 163-174
Maurice, J.P.; Koch, W.J. 1999: Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components. Coronary Artery Disease 10(6): 401-405
Lisy, O.; Burnett, J.C. 1999: Potential future therapies: natriuretic peptides. Coronary Artery Disease 10(6): 389-394
Sousounis, P., J.; Grover, E., K. 2002: Potential future weather patterns over the Great Lakes region. Journal of Great Lakes Research 28(4): 496-520
Stürmer, T.; Brenner, H. 2000: Potential gain in efficiency and power to detect gene-environment interactions by matching in case-control studies. Genetic Epidemiology 18(1): 63-80
Krueger, E.A.; Fraass, B.A.; Mcshan, D.L.; Marsh, R.; Pierce, L.J. 2003: Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. International Journal of Radiation Oncology Biology Physics 56(4): 1023-1037
Lai, D.; Hardy, R.J. 1999: Potential gains in life expectancy or years of potential life lost: impact of competing risks of death. International Journal of Epidemiology 28(5): 894-898
Glimelius, B.; Isacsson, U.; Blomquist, E.; Grusell, E.; Jung, B.; Montelius, A. 1999: Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncologica 38(2): 137-145
Lyon, A.G.; Anderson, S.H. 2003: Potential gas development impacts on sage grouse nest initiation and movement. Wildlife Society Bulletin 31(2): 486-491
Roy, A.M.; Carroll, M.L.; Nguyen, S.V.; Salem, A.H.; Oldridge, M.; Wilkie, A.O.; Batzer, M.A.; Deininger, P.L. 2000: Potential gene conversion and source genes for recently integrated Alu elements. Genome Research 10(10): 1485-1495
Wedekind, C.; Muller, R.; Spicher, H. 2001: Potential genetic benefits of mate selection in whitefish. Journal of Evolutionary Biology 14(6): 980-986
Jayawickrama, Keith, J.S. 2001: Potential genetic gains for carbon sequestration: A preliminary study on radiata pine plantations in New Zealand. Forest Ecology and Management 152(1-3): 313-322, 15 October
Retz, W.; Thome, J.; Durany, N.; Harsányi, A.; Retz-Junginger, P.; Kornhuber, J.; Riederer, P.; Rösler, M. 2001: Potential genetic markers of sporadic Alzheimer's dementia. Psychiatric Genetics 11(3): 115-122
Makarova, K.S.; Wolf, Y.I.; Koonin, E.V. 2003: Potential genomic determinants of hyperthermophily. Trends in Genetics: Tig 19(4): 172-176
Lewis, M.A.; Daniels, C.B.; Moore, J.C.; Chen, T. 2002: Potential genotoxicity of wastewater-contaminated pore waters with comparison to sediment toxicity and macrobenthic community composition. Environmental toxicology 17(1): 63-73
Fernandez, R.J.; Reynolds, J.F. 2000: Potential growth and drought tolerance of eight desert grasses: Lack of a trade-off?. Oecologia (Berlin) 123(1): 90-98
Latini, G. 2000: Potential hazards of exposure to di-(2-ethylhexyl)-phthalate in babies. a review. Biology of the Neonate 78(4): 269-276
Costa, M. 2003: Potential hazards of hexavalent chromate in our drinking water. Toxicology and Applied Pharmacology 188(1): 1-5
Kulasingam, S.L.; Myers, E.R. 2003: Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 290(6): 781-789
Roberts, H.W.; Leonard, D.; Osborne, J. 2001: Potential health and environmental issues of mercury-contaminated amalgamators. Journal of the American Dental Association 132(1): 58-64
Moudgal, C.J.; Lipscomb, J.C.; Bruce, R.M. 2000: Potential health effects of drinking water disinfection by-products using quantitative structure toxicity relationship. Toxicology 147(2): 109-131
Skibola, C.F.; Smith, M.T. 2000: Potential health impacts of excessive flavonoid intake. Free Radical Biology and Medicine 29(3-4): 375-383
Gurjar, B.R.; Mohan, M. 2003: Potential health risks due to toxic contamination in the ambient environment of certain Indian states. Environmental Monitoring and Assessment 82(2): 203-223
Schifano, F. 2000: Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies. Neuropsychobiology 42(1): 25-33
Bopp, L.; Aumont, O.; Belviso, S.; Monfray, P. 2003: Potential impact of climate change on marine dimethyl sulfide emissions. Tellus Series B Chemical and Physical Meteorology 55B(1): 11-32
Theurillat, J.P.; Guisan, A. 2001: Potential impact of climate change on vegetation in the European Alps: A review. Climatic Change 50(1-2): 77-109
Teixeira, J.; Arntzen, J. 2002: Potential impact of climate warming on the distribution of the Golden-striped salamander, Chioglossa lusitanica, on the Iberian Peninsula. Biodiversity and Conservation 11(12): 2167-2176
Darrigran, G. 2002: Potential impact of filter-feeding invaders on temperate inland freshwater environments. Biological Invasions 4(1-2): 145-156
Lemoine, N.; Boehning Gaese, K. 2003: Potential impact of global climate change on species richness of long-distance migrants. Conservation Biology 17(2): 577-586
Cowx, I.G. 2000: Potential impact of groundwater augmentation of river flows on fisheries: A case study from the River Ouse, Yorkshire, UK. Fisheries Management and Ecology 7(1-2): 85-96
Martin, C.W.; Anderson, R.A.; Cheng, L.; Ho, P.C.; van der Spuy, Z.; Smith, K.B.; Glasier, A.F.; Everington, D.; Baird, D.T. 2000: Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Human Reproduction 15(3): 637-645
Toso, C.; Ris, F.; Mentha, G.; Oberholzer, J.; Morel, P.; Majno, P. 2002: Potential impact of in situ liver splitting on the number of available grafts. Transplantation 74(2): 222-226
Moore, S., E.; Clarke, J., T. 2002: Potential impact of offshore human activities on gray whales (Eschrichtius robustus). Journal of Cetacean Research and Management 4(1): 19-25
Henderson, S.B.; Grigson, S.J.W.; Johnson, P.; Roddie, B.D. 1999: Potential impact of production chemicals on the toxicity of produced water discharges from North Sea oil platforms. Marine Pollution Bulletin 38(12): 1141-1151
Pell, J.P.; Sirel, J.M.; Marsden, A.K.; Ford, I.; Walker, N.L.; Cobbe, S.M. 2002: Potential impact of public access defibrillators on survival after out of hospital cardiopulmonary arrest: retrospective cohort study. BMJ 325(7363): 515
Shriner, D.; Nickle, D.C.; Jensen, M.A.; Mullins, J.I. 2003: Potential impact of recombination on sitewise approaches for detecting positive natural selection. Genetical Research 81(2): 115-121
Raisz, L.G. 2001: Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease. American Journal of Medicine 110(Suppl): 43s-45s
Sanders, C.C.; Peyret, M.; Moland, E.S.; Cavalieri, S.J.; Shubert, C.; Thomson, K.S.; Boeufgras, J.M.; Sanders, W.E. 2001: Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital. Journal of Clinical Microbiology 39(7): 2379-2385
Dauby, P.; Scailteur, Y.; Chapelle, G.; De-Broyer, C. 2001: Potential impact of the main benthic amphipods on the eastern Weddell Sea shelf ecosystem (Antarctica). Polar Biology 24(9): 657-662
Fairman, R.M.; Carpenter, J.P.; Baum, R.A.; Larson, R.A.; Golden, M.A.; Barker, C.F.; Mitchell, M.E.; Velazquez, O.C. 2002: Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination. Journal of Vascular Surgery 35(4): 679-685
Lietman, T.; Blower, S.M. 2000: Potential impact of tuberculosis vaccines as epidemic control agents. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 30(Suppl 3): S316-S322
Coscarella, M.A.; Dans, S.L.; Crespo, E.A.; Pedraza, S.N. 2003: Potential impact of unregulated dolphin watching activities in Patagonia. Journal of Cetacean Research and ManagementSpring; 5(1): 77-84
D.Moor, I. 2002: Potential impacts of alien freshwater crayfish in South Africa. African Journal of Aquatic Science 27(2): 125-139
Hunziker, M.; Kienast, F. 1999: Potential impacts of changing agricultural activities on scenic beauty - A prototypical technique for automated rapid assessment. Landscape Ecology 14(2): 161-176
Schifter, I.; Diaz, L.; Lopez Salinas, E.; Avalos, S. 2000: Potential impacts of compressed natural gas in the vehicular fleet of Mexico City. Environmental Science and Technology 34(11): 2100-2104
Ouyang, Y.; Mansell, R.S. 2000: Potential impacts of density-driven pesticide transport upon groundwater contamination: Modeling. Soil and Crop Science Society of Florida Proceedings 59: 150-159
Beuhler, M. 2003: Potential impacts of global warming on water resources in southern California. Water Science and Technology: a Journal of the International Association on Water Pollution Research 47(7-8): 165-168
Cuthbert, F., J.; Wires, L., R.; Mckearnan, J., E. 2002: Potential impacts of nesting double-crested cormorants on great blue herons and black-crowned night-herons in the U.S. Great Lakes region. Journal of Great Lakes Research 28(2): 145-154
Fiori, S.M.; Zalba, S.M. 2003: Potential impacts of petroleum exploration and exploitation on biodiversity in a Patagonian Nature Reserve, Argentina. Biodiversity and Conservation e; 12(6): 1261-1270
Oostingh, G.J.; Davies, H.F.S.; Arch, B.N.; Bradley, J.Andrew.; Taylor, C.J. 2003: Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation. Xenotransplantation 10(3): 278-284
Mcnally, C.; Hackman, B.; Fields, B.S.; Plouffe, J.F. 2000: Potential importance of Legionella species as etiologies in community acquired pneumonia (CAP). Diagnostic Microbiology and Infectious Disease 38(2): 79-82
Ullian, M.E.; Gantt, B.J.; Ford, A.K.; Tholanikunnel, B.G.; Spicer, E.K.; Fitzgibbon, W.R. 2003: Potential importance of glomerular citrate synthase activity in remnant nephropathy. Kidney International 63(1): 156-164
Liebermann, J.; Nawroth, F.; Isachenko, V.; Isachenko, E.; Rahimi, G.; Tucker, M.J. 2002: Potential importance of vitrification in reproductive medicine. Biology of Reproduction 67(6): 1671-1680
Yagasaki, K.; Kousaka, F.; Kitamura, K. 2000: Potential improvement of soymilk gelation properties by using soybeans with modified protein subunit compositions. Breeding Science 50(2): 101-107
Riemma Pierre, M.B.; Maldonado Marchetti, J.; Tedesco, A.C.; Lopes Badra Bentley, M.V. 2001: Potential incorporation of 5-aminolevulinic acid in micelles and stratum corneum lipids liposomes: Fluorescence quenching studies. Revista Brasileira de Ciencias Farmaceuticas 37(3): 355-361
Wilkins, B.T.; Green, N.; Haslam, I.K.; Huntley, D.A.; Dyer, K.R.; Cavrot, D.; Tooley, M.J.; Zong, Y. 1999: Potential incursion of marine sediment inland during storms: The radiological importance of actinides. Journal of Environmental Radioactivity 44(2-3): 371-388
Halkin, A.; Keren, G. 2002: Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease. American Journal of Medicine 112(2): 126-134
Nagy Gasztonyi, M.; Kardos Neumann, A.; Biacs, P.A. 2000: Potential indicator enzymes at broccoli blanching technology. Acta Alimentaria 29(2): 181-186
Quist, M.C.; Guy, C.S.; Pegg, M.A.; Braaten, P.J.; Pierce, C.L.; Travnichek, V.H. 2002: Potential influence of harvest on shovelnose sturgeon populations in the Missouri River system. North American Journal of Fisheries Management ; 22(2): 537-549
Bonnet, F.; Cooper, M.E. 2000: Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. Diabetes and Metabolism 26(4): 254-264
Katusic, S.K.; Colligan, R.C.; Barbaresi, W.J.; Schaid, D.J.; Jacobsen, S.J. 1998: Potential influence of migration bias in birth cohort studies. Mayo Clinic Proceedings 73(11): 1053-1061
Kessler, R.K. 1999: Potential influence of predator presence on diel movements of small riverine fishes in the Ohio River, Kentucky. Journal of the Kentucky Academy of Science 60(2): 108-112
Southwick, L.M.; Grigg, B.C.; Kornecki, T.S.; Fouss, J.L. 2002: Potential influence of sugarcane cultivation on estuarine water quality of Louisiana's gulf coast. Journal of Agricultural and Food Chemistry 50(15): 4393-4399
Faulkner, M.A.; Hilleman, D.E.; Destache, C.J.; Mooss, A.N. 2001: Potential influence of timing of low-density lipoprotein cholesterol evaluation in patients with acute coronary syndrome. Pharmacotherapy 21(9): 1055-1060
Hao, Y.eli; Dick, Warren, A. 2000: Potential inhibition of acid formation in pyritic environments using calcium sulfite byproduct. Environmental Science and Technology 34(11): 2288-2292
Klinke, H.B.; Olsson, L.; Thomsen, A.B.; Ahring, B.K. 2003: Potential inhibitors from wet oxidation of wheat straw and their effect on ethanol production of Saccharomyces cerevisiae: wet oxidation and fermentation by yeast. Biotechnology and Bioengineering 81(6): 738-747
Mathé, C.; Nair, V. 1999: Potential inhibitors of HIV integrase. Nucleosides and Nucleotides 18(4-5): 681-682
Braud, E.; Duflos, M.; Nourrisson, M-Renee.; Tonnerre, A.; Picot, C.; Le Baut, G.; Renard, P.; Pfeiffer, B.; Tucker, G. 2003: Potential inhibitors of angiogenesis. Part I: 3-(imidazol-4(5)-ylmethylene)indolin-2-ones. Journal of Enzyme Inhibition and Medicinal Chemistry 18(3): 243-252
Mountfield, R.J.; Senepin, S.; Schleimer, M.; Walter, I.; Bittner, B. 2000: Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. International Journal of Pharmaceutics (Kidlington) 211(1-2): 89-92, 15 December
Ueda, E.; Yoshikawa, Y.; Ishino, Y.; Sakurai, H.; Kojima, Y. 2002: Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies. Chemical and Pharmaceutical Bulletin 50(3): 337-340
Sharma, K.; Dutta, N.; Hasan, Q.Z. 2000: Potential intake rate and acceptability of some common feeds by goats. Indian Veterinary Medical Journal 24(1): 33-35
Lu, P.; Nakamoto, Y.; Nemoto-Sasaki, Y.; Fujii, C.; Wang, H.; Hashii, M.; Ohmoto, Y.; Kaneko, S.; Kobayashi, K.; Mukaida, N. 2003: Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. American Journal of Pathology 162(4): 1249-1258
Foster, D.R.; Milan, N.L. 1999: Potential interaction between azithromycin and warfarin. Pharmacotherapy 19(7): 902-908
Beorlegui, B.; Aldaz, A.; Ortega, A.; Aquerreta, I.; Sierrasesúmega, L.; Giráldez, J. 2000: Potential interaction between methotrexate and omeprazole. Annals of PharmacoTherapy 34(9): 1024-1027
Kato, Y.; Fujii, T.; Mizoguchi, N.; Takata, N.; Ueda, K.; Feldman, M.D.; Kayser, S.R. 2000: Potential interaction between ritonavir and carbamazepine. Pharmacotherapy 20(7): 851-854
DiTusa, L.; Luzier, A.B. 2000: Potential interaction between troglitazone and atorvastatin. Journal of Clinical Pharmacy and Therapeutics 25(4): 279-282
Aitchison, K.A.; Coker, S.J. 1999: Potential interactions between iloprost and SIN-1 on platelet aggregation and myocardial infarct size in vivo. European Journal of Pharmacology 374(1): 59-69
Tallman, D.L.; Taylor, C.G. 1999: Potential interactions of zinc in the neuroendocrine-endocrine disturbances of diabetes mellitus type 2. Canadian Journal of Physiology and Pharmacology 77(12): 919-933
Laperche, T.; Logeart, D.; Cohen-Solal, A.; Gourgon, R. 1999: Potential interests of heart rate lowering drugs. Heart 81(4): 336-341
Yu, M-Der.; Shaw, S.M. 2003: Potential interference of agents on radioiodide thyroid uptake in the euthyroid rat. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(5): 832-838
Tseng, C.M.; De-Diego, A.; Wasserman, J.C.; Amouroux, D.; Donard, O.F.X. 1999: Potential interferences generated during mercury species determination using acid leaching, aqueous ethylation, cryogenic gas chromatography and atomic spectrometry detection techniques. Chemosphere 39(7): 1119-1136
Pancorbo, P.L.; de Pablo, M.A.; Ortega, E.; Puertollano, M.A.; Gallego, A.M.; Alvarez de Cienfuegos, G. 2001: Potential intervention of Campylobacter jejuni in the modulation of murine immune response. Current Microbiology 43(3): 209-214
Abrams, D.I. 2000: Potential interventions for HIV/AIDS wasting: an overview. Journal of Acquired Immune Deficiency Syndromes 25(Suppl): S74-S80
Llanos, R.J.; Whitacre, C.M.; Miceli, D.C. 2000: Potential involvement of C(3) complement factor in amphibian fertilization. Comparative Biochemistry and Physiology. Part A Molecular and Integrative Physiology 127(1): 29-38
Delahaye, L.; Rocchi, S.; Van Obberghen, E. 2000: Potential involvement of FRS2 in insulin signaling. Endocrinology 141(2): 621-628
Kuwada, Y.; Sasaki, T.; Morinaka, K.; Kitadai, Y.; Mukaida, N.; Chayama, K. 2003: Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. International Journal of Oncology 22(4): 765-771
Eriksen, J.L.; Druse, M.J. 2001: Potential involvement of S100B in the protective effects of a serotonin-1a agonist on ethanol-treated astrocytes. Brain Research. Developmental Brain Research 128(2): 157-164
Fischer, L.J.; Wagner, M.A.; Madhukar, B.V. 1999: Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicology and Applied Pharmacology 159(3): 194-203
Feughelman, M.; Willis, B.K. 2002: Potential involvement of copper and thiol-disulphide interchange in prion proteins' conformational conversion. Medical Hypotheses 59(3): 321-324
Ellis, J.G.; Davila, M.; Chakrabarti, R. 2003: Potential involvement of extracellular signal-regulated kinase 1 and 2 in encystation of a primitive eukaryote, Giardia lamblia. Stage-specific activation and intracellular localization. Journal of Biological Chemistry 278(3): 1936-1945
Van Langendonckt, A.; Casanas-Roux, Fçoise.; Dolmans, M-Madeleine.; Donnez, J. 2002: Potential involvement of hemoglobin and heme in the pathogenesis of peritoneal endometriosis. Fertility and Sterility 77(3): 561-570
Wang, H.; Nemoto-Sasaki, Y.; Kondo, T.; Akiyama, M.; Mukaida, N. 2003: Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through inducing dendritic cell migration into the draining lymph nodes. International Immunopharmacology 3(5): 627-642
Xi, S.C.; Tam, P.C.; Brown, G.M.; Pang, S.F.; Shiu, S.Y. 2000: Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells. Journal of Pineal Research 29(3): 172-183
Imschenetzky, M.; Puchi, M.; Morin, V.; Diaz, F.; Oliver, M.I.; Montecino, M. 1999: Potential involvement of post-translational modifications as a mechanism modulating selective proteolysis after fertilization. Journal of Cellular Biochemistry (Suppl 32-33): 149-157
Jorgensen, M.A.; Trend, M.A.; Hazell, S.L.; Mendz, G.L. 2001: Potential involvement of several nitroreductases in metronidazole resistance in Helicobacter pylori. Archives of Biochemistry and Biophysics 392(2): 180-191
Chu, J.; Lloyd, F.L.; Trifan, O.C.; Knapp, B.; Rizzo, M.T. 2003: Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer. Molecular Cancer Therapeutics 2(1): 1-7
Ying, C. 2000: Potential involvement of tumor suppressor gene expression in the formation of estrogen-inducible pituitary tumors in rats. Endocrine Journal 47(1): 1-5
Kalluri, H.S.; Ticku, M.K. 1999: Potential involvement of tyrosine kinase pathway in the antagonist induced upregulation of the NMDA receptor NR2B subunit in cortical neurons. Brain Research. Molecular Brain Research 65(2): 206-210
Tedeschi, D.; Lombardi, V.; Mancuso, M.; Martelli, F.; Sighieri, C.; Rocchi, A.; Tovani, S.; Siciliano, G.; Murri, L. 2000: Potential involvement of ubiquinone in myotonic dystrophy pathophysiology: New diagnostic approaches for new rationale therapeutics. Neurological Sciences 21(5 Suppl): S979-S980
Li, D.; Zhang, L.; Kneller, J.; Nattel, S. 2001: Potential ionic mechanism for repolarization differences between canine right and left atrium. Circulation Research 88(11): 1168-1175
Cioffi, E., A.; Alston, K., E.; Patel, A., M. 2002: Potential kinetic control of ultrasonic 1H fwdarw 2H isotopic exchange by transition metal doping of Raney-nickel(R) catalysts. Tetrahedron Letters 43(49): 8985-8987
Maune, S.; Meyer, J.E. 2001: Potential koerpereigener antibiotischer Peptide bei der angeborenen Abwehr von Rhinosinusitiden. Allergologie 24(1): 23-32
Hairston Strang, A.B.; Adams, P.W. 1998: Potential large woody debris sources in riparian buffers after harvesting in Oregon, USA. Forest Ecology and Management 112(1-2): 67-77
Kokita, T. 2003: Potential latitudinal variation in egg size and number of a geographically widespread reef fish, revealed by common-environment experiments. ine Biology Berlin 143(3): 593-601
Miyazaki, M.; Akatsuka, Y.; Nishida, T.; Fujii, N.; Hiraki, A.; Ikeda, K.; Tsujimura, K.; Kuzushima, K.; Morishima, Y.; Sato, S.; Ueda, R.; Takahashi, T. 2003: Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells. Clinical Immunology 107(3): 198-201
Berggren, P.; Wade, P.R.; Carlstrom, J.; Read, A.J. 2002: Potential limits to anthropogenic mortality for harbour porpoises in the Baltic region. Biological Conservation 103(3): 313-322
Sato, T.; Dohmae, N.; Qi, Y.; Kakuda, N.; Misonou, H.; Mitsumori, R.; Maruyama, H.; Koo, E.H.; Haass, C.; Takio, K.; Morishima-Kawashima, M.; Ishiura, S.; Ihara, Y. 2003: Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein. Journal of Biological Chemistry 278(27): 24294-24301
Fiebich, B.L.; Hüll, M.; Lieb, K.; Schumann, G.; Berger, M.; Bauer, J. 1998: Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. Journal of Neural Transmission. Supplementum 54: 268-278
Burnett, M.S.; Wang, N.; Hofmann, M.; Barrie Kitto, G. 2000: Potential live vaccines for HIV. Vaccine 19(7-8): 735-742
Schroeder, T.; Nadalin, S.; Stattaus, Jörg.; Debatin, Jörg.F.; Malagó, M.; Ruehm, S.G. 2002: Potential living liver donors: evaluation with an all-in-one protocol with multi-detector row CT. Radiology 224(2): 586-591
Dourdin, N.; Balcerzak, D.; Brustis, J.J.; Poussard, S.; Cottin, P.; Ducastaing, A. 1999: Potential m-calpain substrates during myoblast fusion. Experimental Cell Research 246(2): 433-442
Dar, P.; Javed, A.A.; Ben-Yishay, M.; Ferreira, J.C.; Paterson, A.D.; Gross, S.J.; Chitayat, D.; Morrow, B.E.; Nitowsky, H.M. 2001: Potential mapping of corneal dermoids to Xq24-qter. Journal of Medical Genetics 38(10): 719-723
Miyamoto, R.; Uzawa, N.; Nagaoka, S.; Nakakuki, K.; Hirata, Y.; Amagasa, T. 2002: Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer 95(10): 2152-2159
Niu, Y.; Fu, X.; Lv, A.; Fan, Y.; Wang, Y. 2002: Potential markers predicting distant metastasis in axillary node-negative breast carcinoma. International Journal of Cancer 98(5): 754-760
Mollersten, K.; Yan, J.; Moreira, J., R. 2003: Potential market niches for biomass energy with CO2 capture and storage: Opportunities for energy supply with negative CO2 emissions. Biomass and Bioenergy 25(3): 273-285
Van Schayck, C.P.; Bijl-Hofland, I.D.; Cloosterman, S.G.M.; Folgering, H.T.M.; van der Elshout, F.J.J.; Van Weel, C. 2002: Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma. European Respiratory Journal 19(2): 240-245
Grigioni, M.; Daniele, C.; Morbiducci, U.; Di Benedetto, G.; D'Avenio, G.; Barbaro, V. 2002: Potential mechanical blood trauma in vascular access devices: a comparison of case studies. International Journal of Artificial Organs 25(9): 882-891
Higashida, H.; Taketo, M.; Takahashi, H.; Yokoyama, S.; Hashii, M. 1999: Potential mechanism for bradykinin-activated and inositol tetrakisphosphate-dependent Ca2+ influx by Ras and GAP1 in fibroblast cells. Immunopharmacology 45(1-3): 7-11
Toris, C.B.; Zhan, G.L.; Zhao, J.; Camras, C.B.; Yablonski, M.E. 2001: Potential mechanism for the additivity of pilocarpine and latanoprost. American Journal of Ophthalmology 131(6): 722-728
Nishimura, K.; Nonomura, N.; Satoh, E.; Harada, Y.; Nakayama, M.; Tokizane, T.; Fukui, T.; Ono, Y.; Inoue, H.; Shin, M.; Tsujimoto, Y.; Takayama, H.; Aozasa, K.; Okuyama, A. 2001: Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. Journal of the National Cancer Institute 93(22): 1739-1746
Dosogne, H.; Vangroenweghe, F.éd.ér.; Burvenich, C. 2002: Potential mechanism of action of J5 vaccine in protection against severe bovine coliform mastitis. Veterinary Research 33(1): 1-12
Saball, E.; Salvarrey, M.; Serra, E.; Pico, G.; Elias, M.M.nica 2001: Potential mechanism of fibronectin deposits in acute renal failure induced by mercuric chloride. Molecular and Cellular Biochemistry 226(1-2): 67-75
Mitzner, W.; Brown, R.H. 2000: Potential mechanism of hyperresponsive airways. American Journal of Respiratory and Critical Care Medicine 161(5): 1619-1623
Dagum, P.; Green, G.R.; Glasson, J.R.; Daughters, G.T.; Bolger, A.F.; Foppiano, L.E.; Ingels, N.B.; Miller, D.C. 1999: Potential mechanism of left ventricular outflow tract obstruction after mitral ring annuloplasty. Journal of Thoracic and Cardiovascular Surgery 117(3): 472-480
Gerber, M.A.; Tanz, R.R.; Kabat, W.; Bell, G.L.; Siddiqui, B.p.; Lerer, T.J.; Lepow, M.L.; Kaplan, E.L.; Shulman, S.T. 1999: Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 104(4 Pt 1): 911-917
Pedrozo, H.A.; Schwartz, Z.; Robinson, M.; Gomes, R.; Dean, D.D.; Bonewald, L.F.; Boyan, B.D. 1999: Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Endocrinology 140(12): 5806-5816
Forsten, K.E.; Fannon, M.; Nugent, M.A. 2000: Potential mechanisms for the regulation of growth factor binding by heparin. Journal of Theoretical Biology 205(2): 215-230
Ketter, T.A.; Manji, H.K.; Post, R.M. 2003: Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. Journal of Clinical Psychopharmacology 23(5): 484-495
Donaldson, K.; MacNee, W. 2001: Potential mechanisms of adverse pulmonary and cardiovascular effects of particulate air pollution (PM10). International Journal of Hygiene and Environmental Health 203(5-6): 411-415
Fehniger, T.A.; Bluman, E.M.; Porter, M.M.; Mrózek, E.; Cooper, M.A.; VanDeusen, J.B.; Frankel, S.R.; Stock, W.; Caligiuri, M.A. 2000: Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. Journal of Clinical Investigation 106(1): 117-124
Touzani, O.; Boutin, H.; Chuquet, J.; Rothwell, N. 1999: Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. Journal of Neuroimmunology 100(1-2): 203-215
Monico, C.G.; Persson, M.; Ford, G.C.; Rumsby, G.; Milliner, D.S. 2002: Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria i or Ii. Kidney International 62(2): 392-400
Murphy, A.N. 1999: Potential mechanisms of mitochondrial cytochrome-c release during apoptosis. Drug Development Research 46(1): 18-25
Mahoney, S.P.; Virgl, J.A.; Mawhinney, K. 2001: Potential mechanisms of phenotypic divergence in body size between Newfoundland and mainland black bear populations. Canadian Journal of Zoology 79(9): 1650-1660
Galmarini, C.M.; Thomas, X.; Calvo, F.; Rousselot, P.; El Jafaari, A.; Cros, E.; Dumontet, C. 2002: Potential mechanisms of resistance to cytarabine in AML patients. Leukemia Research 26(7): 621-629
El-Alfy, A.; Schlenk, D. 1998: Potential mechanisms of the enhancement of aldicarb toxicity to Japanese medaka, Oryzias latipes, at high salinity. Toxicology and Applied Pharmacology 152(1): 175-183
Cheek, A.O.; Kow, K.; Chen, J.; McLachlan, J.A. 1999: Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environmental Health Perspectives 107(4): 273-278
Stott, W.T.; Bartels, M.J.; Brzak, K.A.; Mar, M.; Markham, D.A.; Thornton, C.M.; Zeisel, S.H. 2000: Potential mechanisms of tumorigenic action of diethanolamine in mice. Toxicology Letters 114(1-3): 67-75